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ZUSAMMENFASSUNG 
 
Die Leishmaniose ist eine durch einzellige Parasiten der Gattung Leishmania 
verursachte Infektionskrankheit, die durch den Stich von Sandmücken übertragen 
wird. Als erstes klinisches Symptom bildet sich eine nicht abheilende ulceröse 
Wunde von bis zu mehreren cm Durchmesser um die Einstichstelle herum. Nach 
mehreren Monaten kann die Wunde unter Hinterlassung einer Narbe spontan 
abheilen. Falls es sich um eine Infektion mit einer weniger virulenten Form des 
Parasiten gehandelt hat, ist der Patient geheilt und für den Rest des Lebens resistent 
gegen diese Form. Andere Stämme des Parasiten lösen aber die mucocutane Form 
der Krankheit aus, die zu schmerzhaften destruktiven Läsionen der Lippen- und 
Nasenschleimhäute führt, oder die viszerale Form der Leishmaniose, die innere 
Organe angreift und unbehandelt tödlich verläuft. In der Republik Jemen sind die 
cutane und die viszerale Leishmaniose endemisch, werden aber aus Mangel an Geld 
in der Bevölkerung weder hinreichend diagnostiziert noch behandelt. 
Aufzeichnungen über epidemiologische Daten gibt es nur für wenige staatliche 
Krankenhäuser, die Zahl der unregistrierten Fälle ist wahrscheinlich sehr hoch. Um in 
Zukunft zu Kontrollmaßnahmen gegen die Krankheit beitragen zu können, wurde der 
Versuch unternommen, neue molekulare Diagnoseverfahren zu entwickeln, die 
einerseits sehr empfindlich und spezifisch sind, andererseits aber nicht zu kompliziert 
und teuer, so dass sie unter den limitierten Voraussetzungen des Landes realisiert 
werden können. 
Um eine Einblick in das wahre Ausmaß der Krankheit im Jemen zu erhalten, 
wurden die in den staatlichen Krankenhäusern in den letzten Jahren gesammelten 
Daten ausgewertet. Außerdem wurden in verschiedenen Teilen des Landes mehr als 
200 Proben von Patienten mit dem Verdacht auf cutane oder viscerale Leishmaniose 
gesammelt. Dies Proben wurden zunächst im Jemen mikroskopisch auf cutane 
Leishmaniose und mit Hilfe einer sehr unspezifischen Formol-Präzipitation-Methode 
auf viscerale Leishmaniose untersucht. Für einige Proben stand ein kommerzieller 
ELISA zur Verfügung. Von allen gesammelten Blutproben wurde die Plasmafraktion 
und aus angereicherten Leukozyten die DNA gewonnen und für nähere Analysen zur 
Universität Giessen gebracht. 
Von den mittlerweile verfügbaren Sequenzdaten für die Leischmania-Stämme 
L. infantum (viszerale Leishmaniose) und L. major (cutane Leishmaniose) wurden 
II 
 
 
spezifische PCR-Primer für die Entwicklung neuer Diagnoseverfahren abgeleitet. Die 
neuen Verfahren wurden anhand von gereinigter DNA dieser beiden im Labor 
kultivierten Stämme getestet. Zur Entwicklung neuer PCR-Verfahren wurden fünf 
verschiedene Zielsequenzen von hoch-repetitiven Regionen der Genome 
ausgewählt. Zwei Genus-spezifische Tests und ein Test, der die Unterscheidung von 
cutaner und viszeraler Leishmaniose zulässt, wurden erfolgreich entwickelt. 
Die Anwendung dieser Tests für die im Jemen gesammelten Patientenproben 
ergab, dass die PCR-Diagnose wesentlich empfindlicher und spezifischer ist, als die 
traditionell eingesetzten Methoden. Freilich konnte im Rahmen dieser Arbeit weder 
ein vollständiges Bild über die Epidemiologie der Leishmaniose im Jemen noch ein 
endgültig perfektes Diagnoseprotokoll entwickelt werden. Dies wird Aufgabe für die 
folgenden Jahre sein. Immerhin weisen die ermittelten Daten einerseits darauf hin, 
dass die Lage der Leishmaniose im Jemen sehr viel schwerwiegender ist, als offiziell 
zugegeben. Andererseits wurden diagnostische Verfahren entwickelt, die 
ausreichend einfach und so kostengünstig sind, dass sie im Land selbst eingeführt 
werden können. In optimierter Form könnten diese Verfahren zu einem besseren 
Stand der Kenntnis über diese Krankheit im Land führen und auf Dauer zu einer 
Verbesserung der gesundheitlichen Situation der Bevölkerung beitragen
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SUMMARY 
 
Leishmaniasis is an infectious disease caused by different species of 
unicellular Leishmania parasites which are transmitted by the bite of sandflies. As 
first clinical symptome, a non-healing ulcerous wound of up to several centimeters 
diameter forms around the byte of the insect. After several months, the wound may 
heal spontaneously leaving a scar. If the infection was due to a less virulent species 
of the parasite, the patient is healed and resistant against this form for the rest of life. 
However, other strains of the parasite lead to mucocutaneous leishmaniasis which 
lead to painfull destructions of the mucosa of lipps and nose, or to visceral 
leishmaniasis which affects inner organs and is lethal without treatment. Cutaneous 
as well as visceral leishmaniasis are endemic in the Republic of Yemen, but due to 
limiting financial resources, the disease is neither appropriatelytly diagnosed nor 
treated in the population.  
Recorded epidemiological data exist only for some governmental hospitals, 
but the number of unregisterd cases may be huge. In order to shed more light in the 
real extent of the disease in Yemen and to contribute to future control measures, it 
was attempted to design new molecular procedures for the diagnosis, which are, at 
the one hand, highly sensitive and specific, at the other hand not too complicated and 
inexpensive, so that they could be performed under the limiting conditions of the 
country.  
To obtain some insight in the sitation of leishmaniasis, the data registered in 
governmental hospitals during the past years were collected and evaluated. In 
addition, samples from more than 200 patients with suspected cutaneous and 
visceral leishmaniasis were collected in different parts of the country. These samples 
were analysed first in Yemen by microscopy for cutaneous leishmaniasis and by  a 
highly unspecific procedure called formol gel precipitation for visceral leishmaniasis 
Some of the samples were also analysed by a commercial ELISA. From all collected 
blood samples the plasma fraction and DNA from enriched leucocytes were prepared 
and transported to the University of Giessen for further analysis.  
By using the available sequence data of the Leishmania strains L. infantum 
(visceral leishmaniasis) and L. major (cutaneous leishmaniasis), specific PCR 
primers were developed for the design of new diagnostic procedures. The assays 
were tested by means of purifed DNA from these two strains which had been 
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cultivated in the laboratory. Five different target sites from highly repeated sequences 
of the genomes were selected to develop new diagnostic PCR assays. Two assays 
specific for the genus Leishmania, and one assay allowing differentiation of the two 
strains were constucted allowing to discriminate between cutaneous and visceral 
leishmaniasis.  
Applying these tests on the patient samples collected in Yemen revealed that 
PCR diagnosis is more sensitive and specific than the traditional methods used. Of 
course, neither a comprehensive epidemiology of Yemen nor a ultimative perfect 
diagnostic protocol could be obtained during this work. This has to be established 
during the following years. However, the results reveal at the one hand that the 
situation of leishmaniasis in Yemen is more severe than officially stated. At the other 
hand, diagnostic procedures were developed which are simple and inexpensive 
enough to be introduced in the country. When optimized, these techniques may lead 
to more awareness of this disease in the country and to an improvement of the health 
condition of the suffering population.  
V 
 
 
CONTENT 
ZUSAMMENFASSUNG  .....................................................................................................  I 
Summary  .................................................................................................................   III 
CONTENT  ...................................................................................................................  V 
1.  INTRODUCTION ........................................................................................................  1 
1.1  Epidemiology of leishmaniasis  ..........................................................................  1 
1.2  The Parasite  ......................................................................................................  2 
1.3  Immunology of Leishmania infections  ...............................................................  6 
1.4  Leishmaniasis and HIV-coinfection  ...................................................................  8 
1.5  Treatment of leishmaniasis ................................................................................  9 
1.6  Transmission of leishmaniasis  .........................................................................  10 
1.7  Introduction to Yemen  ......................................................................................  11 
1.8  Leishmaniasis in Yemen  ..................................................................................  15 
1.9  Diagnosis of leishmaniasis  ..............................................................................  15 
1.10 Objective of the study  .....................................................................................  18 
2.   MATERIALS AND METHODS  ..........................................................................  20 
2.1  Instruments  ........................................................................................................20 
2.2  Chemicals  ................................................................................................. ......  20 
2.3  Leishmania parasites  .......................................................................................  21 
2.4  Patient samples  .................................................................................................22 
2.5  DNA purification  .................................................................................................23 
2.6  Purification of recombinant Taq DNA polymerase  .............................................24 
2.7  Polymerase chain reaction (PCR)  ...................................................................  26 
2.8  DNA gel electrophoresis  ..................................................................................  28 
3.   RESULTS  ............................................................................................................  31 
3.1  Evaluation of epidemiological data on leishmaniasis in Yemen  ......................  31 
3.2  Collecting samples of leishmaniasis patients in Yemen  ...................... ...........  36 
3.3  Laboratory diagnosis of patient samples in Yemen  .........................................  38 
3.4  Establishing new procedures for the diagnosis of leishmaniasis  .....................  38 
3.5  Establishing new diagnostic PCR procedures  .................................................  39 
3.5.1  Kinetoplast minicircle(kDNA)-specific PCR  ..................................................  41 
3.5.2 18S rRNA specific PCR  ................................................,................................  43 
3.5.3  45-basepair repeat-specific PCR  .............................,....................................  47 
3.5.4  64-basepair repeat-specific PCR  ..................................................................  48 
VI 
 
 
3.5.5  39-basepair repeat-specific PCR  ..................................................................  50 
3.5.6  Compilation of the PCR results  ....................................................................  53 
4.  DISCUSSION  ........................................................................................................  57 
4.1  Epidemiology of leishmaniasis  ........................................................................  58 
4.2  Diagnosis of leishmaniasis  ..............................................................................  61 
4.3  Collection and processing of patient samples  .................................................  61 
4.4  Kinetoplast DNA (kDNA)-specific PCR  ............................................................  62 
4.5  18S ribosomal RNA-specific PCR  ...................................................................  63 
4.6  PCR assays with tandem repeat sequences  ...................................................  65 
4.7  Concluding remarks  ........................................................................................  66 
5.  REFERENCES  .......................................................................................................  68 
ACKNOWLEDGEMENTS  ...............................................................................................  77 
 
1 
 
 
1.  INTRODUCTION 
1.1 Epidemiology of leishmaniasis 
Leishmaniasis is a protozoan parasitic disease which is prevalent in many 
parts of the tropics, subtropics, and Southern Europe. The disease is caused by 
infection with different species of Leishmania, which are transmitted by the bite of 
phlebotomine sand flies. The most common forms of leishmaniasis in the Old World 
are cutaneous leishmaniasis (CL), causing skin sores (review: Reithinger et al., 2007), 
and visceral leishmaniasis (VL), affecting internal organs of the body such as spleen, 
liver, and bone marrow (review: Berman, 2006). A third form of the disease, 
mucocutaneous leishmaniasis (MCL) leading to severe destruction of mucosal areas 
of the mouth, nose and pharynx occurs exclusively in Latin America (reviewed by 
Myler and Fasel, 2008). There is an estimated prevalence of approximately 12 million 
infected people worldwide with 1.0 - 1.5 million new cases of cutaneous leishmania 
and 400,000 - 600,000 new cases of visceral leishmania per year. Leishmaniasis is 
endemic in 88 countries and It has been estimated that 350 million people are at 
threat. Confirmed cases of VL have been reported from 66 countries, 90% of the 
world’s VL occurs in five countries (India, Bangladesh, Nepal, Sudan and Brazil), and 
90% of all CL cases are concentrated in 7 countries (Afghanistan, Algeria, Brazil, 
Iran, Peru, Saudi Arabia and Syria ) showing that Middle East is a focus for 
cutaneous leishmania (Kumar et al., 2007). At present 90% of all MCL occurs in 
Bolivia, Peru and Brazil. It is the most feared form of leishmaniasis because of its 
disfiguring lesions of the face.  
 
 
Figure 1: World distribution of visceral and coutaneous leishmaniasis (source: WHO) 
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1.2  The Parasite 
Leishmania is a protozoon belonging to the order of Kinetoplastida and to the 
family of Trypanosomatidae. The genus Leishmania includes more than 20 different 
species. The parasites exist in two morphological forms: the non-motile intracellular 
amastigote (3-5 micrometer in diameter) living in macrophages of the mammalian 
host, and the motile extracellular promastigote (15-30 micrometer in length, plus the 
flagellum) living in the intestinal tract of the sandfly vector. The amastigotes are able 
to survive inside the macrophages and to multiply within the acidic phagolysosomes 
of these host cells (reviewed by Alexander et al., 1999). 
After infection by a bite of a sandfly, promastigotes enter macrophages, 
transform into amastigotes within 12-24 h and continue multiplication until the host 
cell dies. The released amastigotes infect other macrophages and the infection 
spreads. The parasite contains two striking organelles, the nucleus and the 
kinetoplast. The kinetoplast is found in all protozoa of the order kinetoplastidae 
(Leishmania, Trypanosoma, Plastocrithidia, Crithidia, Endotrypanum, Herpetomonas, 
Leptomonas, Phytomonas, and Wallaceina). It is a rod-shaped mitochondrial 
structure consisting of a DNA network with two types of DNA: about 10,000 
minicircles of approximately 2 kilobasepairs (kb) and 25-250 maxicircles of 
approximately 30 kb each. These together constitute the mitochondrial genome 
(reviewed by Singh 2006 ). 
                     
Figure 2:  Intracellular  and extracellular  leishmanial amastigotes in a Giemsa-stained smear made 
from scrapings of cutaneous lesions (bright-field microscopy, x 1000; pictures from Al-Jawabreh, 
2005). 
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The life cycle of Leishmania: 
During its life cycle, Leishmania is alternating between two major forms: as 
extracellular promastigotes in the gut of the sand fly and as amastigotes inside the 
macrophages of the mammalian host. When the sand fly feeds, promastigotes are 
injected into the skin and are engulfed by host mononuclear phagocytes, where they 
transform into amastigotes and multiply within the phagolysosomal compartment until 
the phagocytic cells are destroyed, releasing the parasites to enter further cells and 
repeat the cycle.The life cycle is shown in Figure 3. 
 
 
 
Figure 3:  Scheme of the life cycle of Leishmania (picture from Rey, 2007) 
 
Clinical symptoms of leishmaniasis 
The three different clinical forms of leishmaniasis, cutaneous leishmaniasis 
(CL), visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) and their 
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causative agents are summarised in Tables 1 and 2. There is a clear correlation 
between Leishmania species and the different clinical manifestations.  
The clinical presentation of cutaneous leishmaniasis begins as an 
erythematous papule which transforms first in a nodule and later on to an ulcerative 
lesion. The lesion heals usually within several months leaving a more or less visible 
scar. This holds for all types of leishmaniasis. However, in case of MCL, lesions 
occure months or years later in the mucosa of the mouth and nose becomming 
gradually painful and eroding underlying tissue and cartilage. In case of VL, leasons 
occure after months in inner organs. 
 
 
 
 
Table 1. Human pathogenic species of Leishmania in Old World, their clinical manifestation 
and geographical distribution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Complex Species 
Clinical 
manifestati
on 
Geographical 
distribution 
Reservoir Vector 
 L. major CL Western and Central Asia 
Middle East, Africa, India 
rodents: Fat sand rat 
(Psammomys.obesus), gerbils  
(Meriones, Rhombomys)  
Phlebotomus 
paptasi 
 L. tropica 
CL, 
L. recidi-
vans 
Western and Central Asia 
Middle East, North Africa, 
Sub-Saharan Savanna, 
India 
humans, dog infections reported, 
hyraxes suspected 
P. sergenti 
L.donovani L. donovani VL, PKDL India, Sudan, Kenya humans P. argentipes 
L.donovani L. infantum 
VL, (CL), 
CVL 
Mediterranean basin 
Middle East, China 
dogs, wild canids (foxes, jackals) P. perniciosus, 
P. ariasi 
 L. aethiopica CL, DCL 
Highlands of Ethiopia and 
Kenya, Sudan 
hyraxes 
P. longipes,  
P. pedifer 
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Table 2. Human pathogenic species of Leishmania in New World , their clinical manifestation 
and geographical distribution. 
 
 
Mucocutaneous leishmaniasis  is manifested solely in South America, 
especially in Brazil, Paraguay, Ecaudor, Bolivia, Peru, Colombia, and Venezuela. The 
highest percentage of the cases occur in Brazil, Bolivia, and Peru. Twenty percent of 
all leishmaniasis patients in Brazil develop MCL. It is a chronic and very serious 
condition, developing years after self-cure of cutaneous lesions. Mucosal lesions can 
progress to involve the entire nasal mucosa and the hard and soft palates. Without 
treatment, the entire nasal mucosa and palates become deformed with ulceration and 
erosion of the nasal septum, lips, and palate. The disease attacks cartilaginous 
areas, but usually spares bony structures, and it can leave extreme disfigurement. It 
can be lethal, mostly by aspiration pneumonia (Myler and Fasel, 2008). 
Visceral leishmaniasis has many different symptoms as the disease 
developes. At the beginning, headache and fever occurre. Lateron, sweating with 
cough, diarrhea, vomiting, bleeding of the gums and weight loss are observed. In the 
late stage of disease, the clinical symptoms transforme to hepatomegally, 
splenomegally, anemia with leucopenia and lymphadenopathy. The mortality ranges 
from one year in acute cases up to 2-3 years in chronic cases. (Garg and Dube 
2006). 
 
 
Complex Species 
Clinical 
manifestation 
Geographical distribution Reservoir Vector 
L. braziliensis L. braziliensis CL, MCL Central and South America forest rodents Lutzomyia sp. 
L. braziliensis L. panamanensis CL Central America, Columbia sloths Lutzomyia sp.  
L. braziliensis L. guyanensis CL Guyana, Brazil sloths Lutzomyia sp.  
L. braziliensis L. peruviana CL Peru, Argentine dogs, humans? Lutzomyia sp.  
L. mexicana L. mexicana 
CL, Chiclero's 
ulcer 
Central and South America, 
Texas 
forest rodents Lutzomyia sp.  
L. mexicana L. amazonensis CL, DCL 
Brazil, Venezuela, 
mostly north of the Amazon 
forest rodents, 
Opossums 
Lutzomyia sp.  
L. donovani L. chagasi 
VL, atypical CL, 
CVL 
Central and South America 
CL in Honduras, Nicaragua 
dogs, wild canids 
Lutzomyia 
longipalpis 
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1.3  Immunology of Leishmania infections 
Within the mammalian host, Leishmania is able to survive as an amastigote in 
phagocytic cells such as macrophages, dendritic cells and neutrophils. The entering 
promastigote forms of the parasites are attacked by the complement system, 
however, some of them survive and enter the macrophages via the C3 receptor 
(Figure 4).  
 
 
 
Figure 4: Life cycle of L. major. After inoculation of metacyclic promastigotes of L. major into 
the skin by the bite of a sand fly, parasites activate complement and are partially lysed. 
Surviving parasites utilize C3 to invade macrophage (MΦ) host cells via CR3, and – within 
these cells – they transform into obligate intracellular amastigotes. MΦ infection does not 
lead to cell activation (e.g. IL-12 release). Inside of MΦ, parasites replicate and more 
amastigotes are released into the tissue. The life cycle of L. major is completed upon uptake 
of parasites by another bite of a sand fly. (Reproduced from von Stebut, 2007) 
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Because the organisms are located intracellularly, an effective immune 
response includes mainly cell-mediated mechanisms for resistance to the parasite. 
Cytokines produced by T cells, natural killer (NK) cells, and antigen-presenting cells 
(APC) play an essential role in this process. (Roberts, 2006). The outcome of 
infection is determined by the parasite species and the host’s immunological 
response. The CD4+ T helper cell is critical with animal models demonstrating that 
cure is associated with strong IFN-gamma, interleukin (IL)-2 and IL-12 responses in 
the absence of classical Th2 cytokines or IL-10.  
The outcome of the infection appears also to be influenced by the saliva of the 
transmitting sand fly. The saliva contains a repertoire of pharmacologically active 
molecules that hampers the host's haemostatic, inflammatory and immune 
responses. This interferes with the early interactions between Leishmania and the 
host's immune response. There are concrete indications that the host response 
against sand fly saliva influences disease outcome in leishmaniasis (Andrade et al., 
2007, Figure 5). 
 
 
 
 
Figure 5: Effects of Lutzomyia longipalpis saliva on vertebrate host. When the sand fly saliva 
is injected into host skin, it induces an inflammatory cell infiltration (1), and antibody 
production (2). In this scenario, immune complexes are formed [20] at early phases of 
exposure. Moreover, sand fly saliva also modulates co-stimulatory molecules and cytokine 
release by antigen presenting cells. (Reproduced from Andrade et al., 2007) 
 
8 
 
 
Cutaneous leishmaniasis (CL) is worldwide by far the most frequent 
consequence of the disease. In the Old World, CL is also known as Oriental Sore, 
Delhi boil, Baghdad boil and Quetta Sore (Myint et al., 2008) and is usually caused 
by L. major, L, tropica and L. aethiopica. In Latin America, CL is caused by other 
Leishmania strains (see Table 2). This form of disease heals spontaneously after few 
months leading to life-long immunity against re-infection and is normally not treated 
with drugs. Healing is characterized by induction of IFN-gamma releasing T-cells 
(Kurtzhals et al., 1994), whereas failure to cure is associated with elevated levels of 
IL-4 with low IFN-gamma responses from Leishmania-specific T-cells (Ajdary e al., 
2000). As all forms of leishmaniasis begin with a cutaneous lesion at the site of entry 
of the parasites, clear diagnostic differentiation at this stage would be needed to 
discriminate CL from the severe forms MCL and VL.  
MCL is mostly caused by Leishmania species belonging to the L. braziliensis 
complex. However, it can also be caused by L. panamanensis (Barral et al., 1992). 
The serious hazard of developing MCL after cure of CL is estimated to be up to 40%. 
The immunology of MCL has not yet been studied in detail.  
Visceral Leishmaniasis (VL) or Kala azar is usually caused by members of the 
L. donovani complex (Singh 2006). L. donovani is found to be the causative agent in 
endemic areas of Bangladesh, India and Sudan, L. d. infantum is widly distributed in 
Middel East and in Mediterranean countries and L. d. chagasi is the only causative 
agent in the New World. VL is characterized by suppression of T cell activity in acute 
disease due to increased expression of IL-10 (Ghalib et al., 1993). Increased 
expression of classical Th2 cytokines has been reported in VL with elevated levels of 
IL-4 particularly associated with treatment faillure (Sundar et al., 1997). Elevated 
levels of IL-13 have been observed in active disease that returned to normal after 
successful treatment (Babaloo et al., 2001).  
 
 
1.4  Leishmaniasis and HIV-coinfection 
Leishmaniasis has been identified as a frequent opportunistic infection in 
patients infected with human immunodeficiency virus type-1 (HIV-1) which amplifies 
in cells of the immune system thus reducing the ability to resist other infections. It has 
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been observed that the visceral form of leishmaniasis accelerates the course of HIV-
1 disease progression and shortens the life expectancy of persons in areas where 
both diseases are endemic (Pourahmad 2009). 
The greatest prevalence of co-infection with HIV and Leishmania have been 
observed in the Mediterranean basin with more than 2,000 cases reported from 35 
countries to the World Health Organization. About 90 per cent of all cases come from 
Spain, Italy, France and Portugal. In Africa the increase of co-infection with HIV has 
been reported in Ethiopia and Sudan which is mainly caused by social troubles such 
as war or increase of population in urban and suburban areas in regions where both 
vector and reservoir are abundant. In South America, the majority of co-infections 
has been reported in Brazil.(Cruz et al., 2005) 
 
 
1.5  Treatment of leishmaniasis 
Pentavalent antimony-containing compounds are the main drugs used to treat 
leishmaniasis. These drugs need to be delivered by intramuscular or intravenous 
routes daily for 4-6 weeks and are quite toxic leading to severe side effects including 
serious heart arrhythmias, pancreatitis and and hepatic dysfunction. They cannot be 
used for pregnant women. In rich countries the fungizide amphotericin B in liposomal 
form in has become the treatment of choice. Since short time, a new oral agent, 
Miltefosine, has been licensed in India, Germany and Colombia for use in adults and 
children. Both drugs have lower side effects and show high cure rates. However, the 
cost of these agents restrict a more widespread use (Roberts, 2006). 
By these reasons, less virulent cutaneous leishmaniasis is normally left to self-
healing. Treatment is only important for the severe forms MCL and VL and to reduce 
scarring when cosmetically sites are involved. Plastic surgery may be needed to 
correct disfigurement by destructive facial lesions caused by cutaneous 
leishmaniasis. The most common drugs used for treatment of leishmaniasis, their 
application and side effects are listed in Table 3.   
 
 
 
 
 
 
 
10 
 
 
Table 3 Treatments for cutaneous, muco-scutaneous and visceral leishmaniasis  
              (modified according to Roberts 2006) 
 
    Drug     Regimen     Comments/side 
effects 
 
Cutaneous 
   Antimonials    Observation alone     60–70% cure rate 
   Antimonials    IM/IV 20 mg/kg daily for 10 days 
   Paromomycin   IL 1 ml/lesion weekly for 8 weeks   Pain/erythema 
   Miltefosine    Topical bd daily for 2 weeks    Pain/erythema 
   Fluconazole    PO 2.5 mg/kg daily for 28 days 
   Pentamidine   PO 200 mg daily for 6 weeks   
 Nausea/vomiting 
   Imiquimod    IM 8 mg/kg daily for 7 days    Adjunctive therapy 
 
Muco-cutaneous 
   Antimonials   IM/IV 20 mg/kg daily for 20 days 
   Liposomal amphotericin  IV 3 mg/kg daily for 20 days    Renal failure/low K+ 
 
Visceral 
   Antimonials    IM/IV 20 mg/kg daily for 20 days 
   Miltefosine    PO 2.5 mg/kg daily for 28 days 
   Amphotericin B   IV 1 mg/kg daily for 5 days    Renal failure/low K+ 
   Liposomal amphotericin  IV 3 mg/kg daily for 5 days    Renal failure/low K+ 
   Paromomycin   IM 20 mg/kg daily for 21 days 
_____________________________________________________________________________________________________ 
 
1.6  Transmission of leishmaniasis 
The transmission of leishmaniasis depends on many different ecological and 
biological factors. Leishmania can only be transmitted, if suitable conditions are 
present for both the reservoir and the vectors. Only if the host animal and the sandfly 
species live close enough together, transmission of the parasite is possible. 
Cutaneous leishmaniasis occurs either as a zoonotic or as an anthroponotic 
infection. The transmission of Leishmania major causing Old World cutaneous 
leishmaniasis in humans is a rural zoonotic disease with rodents serving as the 
reservoir. In zoonotic leishmaniasis, humans are only accidental hosts and usually 
not directly involved in the transmission cycle (Al-Jawabreh et al., 2008). New 
endemic foci of CL may occur, when environmental changes take place such as rise 
of population under poor housing conditions (slums) or specific forms of agriculture. 
In the Middle East, the fat sand rat (Psammomys obesus) is the main reservoir 
animal. In addition, jirds (Meriones crassus) have been found to host the parasite 
(Jaffe et al., 2004). In the arid regions of central Asia, Iran and Afghanistan, the great 
gerbil (Rhombomys opimus) is main reservoir of L. major (Wasserberg et al., 2002). 
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The main insect vector for transmission of L. major is the sand fly species 
Phlebotomus papatasi (EL- Badry et al., 2008). In Kenya, L. tropica has been 
isolated from hyraxes (procavia ssp. German: Klippschliefer) (Sang et al., 1993). 
Hyraxes are also the main reservoir of L. aethiopica in Ethiopia (Ashford et al., 1973).  
In some urban centers of Middle East and Asia exist completely anthroponotic 
life cycles of the parasites, i.e. human beings are the main or only reservoir host. In 
such places cutaneous leishmaniasis caused by L. tropica can be highly endemic, 
but no animal reservoir is to be recognized. In Central and South Western Morocco, 
the transmission of L. tropica is anthroponotically as well. The parasite is mainly 
transmitted by sandflies of the species Phlebotomus sergenti (Ramaoui et al., 2008). 
 
 
Prevention of infection 
The best way to prevent leishmaniasis is by personal protection from sandfly 
bites, which includes for example long sleeve clothing in evening hours. The use of 
insecticides for house and space spraying reduce sandfly populations, and fine-
weave pyrethroid-impregnated bednets have successfully been used in Burkina 
Faso, Sudan, and Columbia (Markle and Makhoul, 2004). 
 
 
1.7 Introduction to Yemen 
The Republic of Yemen – once ruled by the Queen of Sheba, and still in our 
days full of historical tresures from ancient times - is situated in the southwestern 
area of the Arabian peninsula. The country which covers about 460,000 km2 is 
bordered by Saudi Arabia in the north, by the Arabian Sea and Indian Ocean the 
south, by the Red Sea in the west and by the Sultanate of Oman in the east (Figure 
6) 
Yemen is characterized by varied landscape, diversified terrain and climate. 
Overlooking the coastal plains are ranges of low and high altitude mountains, many 
of which are terraced. Throughout, Yemen maintains plateaus, hills and plains. These 
can be wide in some areas or narrow in others. Green wadis (or valleys) are 
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riverbeds for the rainwater runoff during the two rainy seasons in December to 
February and May to June. Desert extends eastward and northward. This natural 
terrain is broken down into the coastal region, the plateaus, the mountainous 
highlands and desert of the Empty Quarter. 
 
 
Figure 6: Map of the Republic of Yemen 
(source: http://www.maparchive.org/details.php?image_id=415 
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The most populated coastal area includes the lower plains overlooking the 
Red Sea, the Gulf of Aden and the Arabian Sea. The plains are interconnected to 
form a coastal strip starting with the Tehama (meaning hot land), which extends from 
Gizan in the North to Bad Al-Mandab Strait southwards. This region also includes a 
range of mountains, with an altitude ranging between 200 to 900 meters above sea 
level. It also encompasses the coastal plains tapering into the Gulf of Aden. The total 
length of this coastline reaches approximately 2,000 km and covers approximately 
3000 km2. Administratively, this area is divided in the governates Aden, parts of 
Hadhramaut and Al-Mahara. 
The Plateaus Region in the East is reaching elevations as hihg as 1,000 
meters is weakly populated and extends towards the Empty Quarter desert, with 
water flowing down from the mountains to wadis like famous Wadi Hadhramaut, 
which has been an essential centre of Arabian culture since the second millennium 
b.C. The peripheries of the Plateaus Region intertwine from the east with the rough 
terrain of Ramlat Al-Sabein and desert of Saada, Al-jawf, Shabwa, Hadhramaut and 
Al-Mahara. 
The Mountain Highlands Region was formed as a result of the African split 
from Asia, which led to the cleavage forming the Red Sea and the Gulf of Aden. The 
altitude of Yemen's mountain range reaches between 1,000 to 3,600 meters above 
sea level. The summit of Jabal (Mount) Al-Nabi Shu'aib with an altitude of 3,666 
meters and a snowy cap during winter time is the highest elevation in the Arabian 
Peninsula. At the foot of the highland are different flat basins and many wadis with 
land for agriculture and water reservoirs. Wadis flowing into the Gulf of Aden and the 
Arabian Sea include Wadi Tiban, Wadi Bana, Wadi Ahwar and Wadi Hadhramaut. 
Other wadis slope eastward towards the desert (Wadi Khabb, Wadi Al-Jawf and Wadi 
Adhanah) or towards the North and Northeast (Wadi Harib, Wadi Marakhah, Wadi 
Jirdan, Wadi Aiwah Al-Sai'ar, Wadi Rammah and Wadi Sha'at). Administratively, the 
Mountain Highlands Region comprises the Governorates of Raimah, Sana'a, Hajjah, 
Al-Mahweet, Sa'ada, Dhamar, Ibb, Ta'ez, AI-Beidha and Al-Dhali'a. 
The almost unpopulated Empty Quarter represents the desert region of 
Yemen. It is intertwined with wild vegetation, especially in the peripheries that run into 
the Plateau Region through wadis and sand beds. Vegetative life and water get 
scarce inward of the Empty Quarter, whereas shifting sand dunes increase. These 
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dunes bury archeological sites and ruins. Former names of the Empty Quarter region 
were Rijraj Sea, the Safi Sea, the Great Desert and Al-Ahqaf Desert. 
 
Climate  
Yemen is a country with a high level of solar radiation all around the year. 
Diversity in topography provides varied climate. In the coastal areas, the climate is 
characterized by high temperatures and humidity during summer and moderate 
temperatures during winter. Moderate climate prevails in the western slopes, 
plateaus and flat land. Temperatures reach 10-30° C entigrade and may  fall below 0° 
C in winter. Humidity can reach 80%. The annual average rainfall is 300 to 1,000 
mm. The climate in the eastern parts of Yemen differs considerably with 
temperatures exceeding 40° C during the summer fall ing to 10°-15° C in the winter. 
Annual rainfall does not exceed 50-100 mm, especially in the periphery of the Empty 
Quarter. The transitory area is found between these two climatic regions. extending 
from north and east of Sana'a to the western parts of Marib. The entire area of 
Yemen is affected by monsoon winds blowing from the east due to low air pressures 
in the west. The monsoons are usually accompanied by rain in the summer and 
lesser rain in winter. 
 
Population 
The population of Yemen is 19.7 million people according to the population 
census of 2004. The annual population growth rate has declined from 3.7 % in 1994 
to 3.0 %. This is seen as a major success in curbing population growth.  
About 27 % of the population lives in major cities and 73 % live in rural areas. 
The movement of people is a decisive factor in the re-distribution of population 
among the different regions of Yemen. The rate of urban growth reaches 9 % in the 
Capital Secretariat (City of Sana'a). Sana’a includes about 28 % of the total urban 
population of the country followed by Hodeida and Aden with 16 % and 14 %.  
With a per capita-income of only 450 Euro per year (in 2008), Yemen is by far 
the poorest country in Near and Middle East. More than two thirds of the inhabitants 
live from less than two US-Dollars per day. The health system of the country is 
underdeveloped, children and mother mortality are high, and life expectancy is low. 
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Medical installations and qualified personell are limited and the population, especially 
women and children, suffer from deficiencies of medical care. Under these 
circumstances, there exist no much information on specific diseases such as 
leishmaniasis. 
 
1.8  Leishmaniasis in Yemen 
There are very few reports on leishmaniasis in Yemen in the international 
literature. Even though it is not well documented, the disease seems to be endemic in 
the country, and is primarily widespread in arid and semiarid areas. It is also endemic 
in in the plateau and mountainous areas of Hajjah and Amran governorates. 
Cutaneous leishmaniasis has first been reported in Sana’a as early as 1933 (Sarnelli 
1933). In 1986, Leishmania tropica was identified in 18 patients in Naghdi Dhamran 
and Wadi Dhamran (Rioux 1986). Another study revealed 42 cases of cutaneous 
leishmaniasis in the Hajjah governorate and neighboring regions (reviewed by Khatri 
et al., 2006). Leishmania major as well as Leishmania tropica account for the majority 
of infections in Yemen. Pratlong et al. (1995) reported from a patient who developed 
localized cutaneous lesions due to Leishmania donovani sensu stricto, following a 
stay in Yemen. The patient lived in southern France and visited Yemen for 2 weeks 
during November 1992 when he was bitten by sandflies. He had not traveled 
elsewhere in the previous 3 years. Studies of Leishmania strains in Yemen and in 
countries close to Yemen suggest that coutaneous leishmaniasis is mainly caused by 
L. major and L. tropica, whereas the agent of visceral leishmaniasis is L. infantum 
(Boyer, 1993; Piarroux et al., 1995; Khatri et al., 2006; Nasereddin et al., 2009) 
 
1.9  Diagnosis of Leishmaniasis  
Parasitological diagnosis is considered to be golden standard in diagnosis of 
leishmaniasis because of its high specificity. It includes microscopic examination of 
Gimsa- stained smears derived from biopsies of cutaneous lesions, or aspirates from 
lymph nodes, bone marrow, or spleen. Histopathological examination of fixed lesion 
biopsies or culture of biopsies is also performed. Microscopic examination is still a 
widespread method in endemic countries, because it is quite inexpensive and does 
not require sophisticated laboratory equipment. In contrast, culture in combination 
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with multilocus enzyme electrophoresis allowing identification of the parasite species 
and leading to definite diagnosis requires a wealth of technical training and takes 
long time to obtain results. Disadvantages of microscopy and culture are the low 
sensitivity, especially in the chronic stage of the disease when the number of 
parasites decreases (Reithinger, 2007). 
 
Serological methods 
Indirect diagnostical methods include the relatively sensitive, but not highly 
specific diagnostic procedure is the Leishmanin skin test (LST) also known as the 
Montenegro reaction (Montenegro, 1926). Leishmanial antigen (killed promastigotes), 
or disrupted promastigotes in pyrogen – free phenol saline - is applied intradermally 
and a delayed hypersensitivity reaction can be observed. A cross-reaction has been 
reported with tuberculosis. Leishmanin skin test is used as an indicator of the 
distribution of cutaneous and mucocutaneous leishmaniasis in both humans and 
animals, in visceral leishmaniasis usually only after treatment and cure (Sadeghian et 
al., 2006).  
Most sensitive and specific test especially for the diagnosis of visceral 
leishmaniasis include serological methods such as the enzyme linked 
immunosorbent assay (ELISA). Since few years, a highly specific recombinant 
antigen, K39, which is part of a kinesin-related gene and contains a repetition of 39 
amino acid residues has been developed and is being widely used for diagnosis 
meanwhile. K39-ELISA was found to be more sensitive and specific than 
immunoassays including crude perasite extracts such as the direct agglutination test 
(DAT) and soluble antigen (SA) ELISA used before. In India, recombinant K39 has 
been widely used for detecting visceral leishmaniasis even in immunocompromised 
patients with VL-HIV co-infection (Singh, 2006). 
Western blots have been used as a diagnostic tool to identify by anti-
leishmanial antibodies by Leishmania antigens. In the western blot technique several 
antigenic products can be distinguish by different antibodies in one assay. Before 
introduction of recombinant K39, the western blot technique proved to be the most 
sensitive and specific serological methods for diagnosis of leishmaniasis. The 
development of the rk39 dipstick test it is successfully employed in the diagnosis of 
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VL as will as PKDL in India. It was found to be 95-100 % sensitive when tested in VL 
Patients. (Salotra et al., 2003) 
The direct agglutination test (DAT) is a comparatively simple and inexpensive 
test suitable for field work and for screening patient sera in the laboratory (Harith et 
al., 1986). The method is based on the agglutination of stained promastigotes 
available either as a suspension or in a freeze- dried form with Leishmania-specific 
antibodies. The freeze-dried form is more stable and improves the usefulness of the 
DAT in the field. The sensitivity of the test is almost 100 %, and the specificity for 
leishmaniasis is equally high except of countries with Chagas disease, where 
crossreactivity with Trypanosoma cruzi is being observed (El Harith et al., 1988). 
 
Molecular methods 
The polymerase chain reaction (PCR) has offered a new dimension in the 
diagnosis and characterization of various infectious agents, enabling to perform tests 
in few hours. It proved to be very useful for the diagnosis of leishmaniasis. In recent 
studies many different PCR assays have been developed for the diagnosis of 
Leishmania DNA in a variety of clinical samples such as peripheral blood, skin 
biopsies, bone marrow and lymph node aspirates. In several studies comparison of 
PCR was found to be more sensitive than microscopy and culture for diagnosis of VL, 
especially in immune- compromised patients. Sensitivities between 80 and 90 % 
have been reported which is markedly better than microscopy and culture 
(approximately 55 % sensitivity each). Different targets have been chosen for the 
PCR, multicopy sequence repeats such as genes for ribosomal RNAs and kinetoplast 
DNA are usually prefered (Schallig and Oskam, 2002). The genes of the small 
subunit ribosomal RNA (SSUrRNA) consist of both conserved and variable regions 
which are almost species-specific and can be used for the development of specific 
diagnostic approaches. The kinetoplast DNA (kDNA) contains the most highly 
repetitive sequences in Leishmania. It consists of approximately 10.000 copies of 
plasmid-like minicircles of different size, but all of them share a conserved region of 
120-140 bp. This region contains two short highly conserved sequences which are 
perfectly homologous in all Leishmania species. This fact has been utilized for a 
genus-specific diagnostic PCR approach (Review: Henk et al., 2002). 
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1.10  Objective of the study 
The objective of this study was to shed some light in the epidemiology of 
leishmaniasis in the Republic of Yemen and to develop simple molecular approaches 
for the detection of the disease under the limited economical conditions of the 
country. The official data on leishmaniasis provided by the government are 
incomplete and may only indicate the peak of an iceberg of under-reported cases.  
Diagnosis of cutaneous leishmaniasis in Yemen is based solely on 
microscopic examination, which yields a good sensitivity in acute infection but is of 
limited use in the chronic phase of the disesase when the number of parasites in 
biopsy samples decreases. Diagnosis of visceral leishmaniasis by microscopic 
examination of spleen aspirates is rarely used because it is technically demanding 
and needs trained personell. Instead, a formol gel test is wildly used for the diagnosis 
of visceral leishmaniasis because it is very cheap, but the specificity reaches hardly 
50 %. In order to get a more detailed aspect on the epidemiology of leishmaniasis in 
Yemen and to contribute to a more specific and sensitive diagnosis, the following 
issues were addressed:  
• To collect information of incidence of leishmaniasis in different parts of Yemen. 
• To collect information on control measures and treatment of leishmaniasis in 
Yemen. 
• To take blood and tissue samples from patients suspected to have cutaneous 
or visceral leishmaniasis. 
• To analyse the tissue samples of CL patients (Giemsa-stained smears from 
the wound) by microscopy in Yemen. 
• To harvest lymphozytes from the blood samples and extract DNA for later 
PCR analysis. 
• To prepare serum (or plasma) from the blood samples for later immunological 
analysis. 
• To establish affordable procedures for molecular diagnosis of human 
leishmaniasis in the laboratory in Giessen by designing primers which lead to 
high specificity and  sensitivity in the PCR assays. These procedures had to 
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bo be simple, easy to perform and inexpensive in order to make their use 
realistic in a poor country. 
• To increase sensitivity and specificty of diagnostic tests by developping nested 
PCR assays. 
• To transfer the new molecular technology to Yemen in order to improve 
diagnosis of the disease in the country. 
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2  MATERIALS and METHODS 
2.1 Instruments 
Gel electrophoresis systems 
Horizontal minigel system (8 x 8 cm) AGS, Heidelberg, Germany 
Vertical minigel chamber (8 x 10 cm) Keutz, Reiskirchen, Germany 
Power supply EPS 500/400  Pharmacia, Freiburg, Germany 
Shakers 
Certomat R     Braun, Melsungen, Germany 
Vortex Genie 2    Scientific Industries, Bohemia, NY, USA 
Centrifuges 
Cooling centrifuge Beckman J2-21,  Beckman Instruments, Summerset, USA 
Microfuge: Biofuge Pico   Heraeus Instruments, Hanau, Germany 
Multifuge 3     Heraeus Instruments, Hanau, Germany 
Waterbath  
GFL Wasserbad 1013    Gesellschaft für Labortechnik, Burgwedel, 
                           Germany 
Thermocyclers 
T1 Thermocycler 96   Biometra GmbH, Göttingen, Germany 
Primus 96     MWG Biotech AG, Ebersberg, Germany 
Photographic equipment 
UV Transilluminator    Herolab GmbH, Wiesloch, Germany 
Polaroid MP-4 Land Camera   Polaroid Corporation, Cambridge, MA, USA 
Film: Polaroid 667 Professional   Polaroid Corporation, Cambridge, MA, USA 
 
2.2  Chemicals 
Acrylamid      Serva, Heidelberg, Germany 
Agarose for gel electrophoresis   Sigma-Aldrich, Munich, Germany 
Ammoniumpersulfate (APS)   Serva, Heidelberg, Germany  
Ammoniumsulfate     Carl Roth GmbH, Karlsruhe, Germany 
Ampicillin      Sigma-Aldrich, Munich, Germany 
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Adenil Triphosphate (ATP)   Carl Roth GmbH, Karlsruhe, Germany 
Biorex 70 resin     BIO-RAD Laboratories, Hercules, USA 
Coomassie Brilliant Blue R250   Serva, Heidelberg, Germany 
Dithiothreitol (DTT)     Biomol, Heidelberg, Germany 
dNTP-Set (100 mM per dNTP)   Carl Roth, Karlsruhe, Germany 
Ethidium bromide     Serva, Heidelberg, Germany 
Ethylenediaminetetraacetic acid (EDTA) Serva, Heidelberg, Germany 
Fetal calf serum     Sigma-Aldrich, München, Germany 
Glutamine      Carl Roth, Karlsruhe, Germany 
Guanidiniumhydrochlorid (GuHCl)  ICN Biomedicals, Germany 
Heparin sepharose     Pharmacia-LKB, Upsala, Sweden 
Medium 199      Sigma-Aldrich, München, Germany 
ß-Mercaptoethanol     Serva, Heidelberg, Germany 
MEM Earle’s Medium    Gibco BRL, Eggenstein 
N,N,N‘,N‘-Tetramethylethylendiamine (TEMED)  Serva, Heidelberg, Germany 
Oligonucleotides     MWG-Biotech, Ebersberg, Germany 
Phenylmethylsulphonylfluoride (PMSF)  Carl Roth GmbH, Karlsruhe, Germany 
Penicillin/Streptomycin    Carl Roth GmbH, Karlsruhe, Germany 
Polyethyleneimine     Sigma-Aldrich, München, Germany 
Tween-20       Serva, Heidelberg, Germany 
Triton X-100      Merck, Darmstadt, Germany 
Tris (hydroxymethyl) aminomethane  Carl Roth GmbH, Karlsruhe, Germany 
 
2.3  Leishmania parasites 
L. major and L. infantum were obtained from Prof. Bernhardt Fleischer, Bernhard-
Nocht-Institut, Hamburg. They were cultivated in vitro using either medium 199  plus 
10 % heat-inactivated fetal calf serum, or Earle’s medium supplemented with 
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glutamine and 10 % heat-inactivated fetal calf serum at 30°C in the presence of 5 % 
CO2. A mixture of penicilline and streptomycin (from 100 x penicillin/streptomycin 
stock solution) was added to prevent bacterial contaminations. After 3-4 days, 
parasites were transfered in 3 volumes of fresh medium and further incubated. The 
parasites were harvested by centrifugation for 20 min at 2.000 x g and frozen.   
 
2.4  Patient samples 
Blood samples were collected from approximately 150 patients visiting 
hospitals in six different regions in north Yemen and the central blood bank in Sana’a 
with lesions suspected to be cutaneous leishmaniasis over a period of more than two 
years. Skin scrapings were taken from the borders of the wound and analysed 
microscopically. As this kind of diagnosis has a limited sensitivity (approximately 70 
%), all blood samples were kept and processed as described below for further 
analysis by molecular methods lateron. Most of the examined patients came from 
endemic areas (urban as well as rural), had been travelling inside the country, or had 
been stationed as soldiers in the desert area. Blood samples from 26 patients with 
suspected visceral leishmaniasis were collected in several locations in the western 
part of Yemen.  
3-5 ml of collected blood were processed immediately by sedimenting the 
blood cells using a manual centrifuge (see Figure 10 in the Result section). Plasma 
and buffy coat were collected as described below. Plasma was conserved by the 
addition of 50 % glycerol, and the DNA of the purified buffy coat was stabilized in 500 
µl of guanidinium-hydrochloride lysis buffer. Whenever possible, the samples were 
kept at 4°C, however, they were transported for sev eral days at ambient 
temperatures without loss of biological activity. 
 
Microscopical analysis of skin scrapings 
Small quantities of tissue obtained by skin scrapings were smeared on glass 
slides, air dried and fixed with methanol for a few seconds. Giemsa stain was filtered 
and diluted 1:20 with phosphate buffer (pH 7.2). After 20 minutes of staining the 
slides were washed with tap water and air dried. The stained smears were examined 
under the microscope with a 40 x lens and with a 100 x oil immersion lens. If at least 
one intra- or extra-cellular amastigote with a distinctive kinetoplast was found the 
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GuHCl lysis buffer 
24 g GuHCl  
2 ml 1 M Tris/HCl pH 7.0 
2 ml of 0.5 M EDTA  
0.5 ml Tween 20 
smear was declared positive. When no amastigotes were seen after 15 minutes of 
inspection, the smear was declared negative. Many of the patient smears were 
double checked, the observations were in concordance. All samples collected during 
visits six different region and central blood bank were stained and examined in 
Yemen. 
 
2.5  DNA purification 
GuHCl lysis buffer (DNA extraction buffer) 
5 M Guanidinum hydrochloride (GuHCl) 
40 mM Tris/HCl pH 7.0 
20 mM EDTA  
1 % Tween 20  
 
Ethanol washing buffer 
70 % ethanol 
10 mM TrisHCl pH 7.0 
 
Silica suspension for purification of nucleic acids 
50 g of silica (SiO2) powder (Sigma No. S 5631) were suspended in 250 ml of 
water, centrifuged for 3 min at 5000 x g, the milky supernatant was discarded, the 
sediment resuspended in another 250 ml of water and centrifuged again. The 
procedure was repeated 3-5 times more until supernatant became clear. The 
sediment was suspended in one volume of water and kept in 2 ml aliquots at -20°C. 
 
Isolation of DNA using guanidinium-hydrochloride/silica 
The following procedure is appropriate to isolate total DNA from cultivated 
Leishmania parasites (10 to 20 mg).  500 µl of guanidinum lysis buffer were added to 
10-20 µl sedimented parasites, vortexed and incubated for 10 min at 65°C. 
Thereafter the solution was vortexed vigorously again to reduce viscosity.  After 3 
min centrifugation at 13.000 rpm in a minifuge, the supernatant was transferred to a 
new tube and 10-20 µl of silica suspension were added, mixed and incubated for 5 
min at room temperature.  The sample was centrifuged for 30 s at 13.000 rpm, the 
Ethanol washing buffer 
70 ml ethanol 
1 ml 1 M Tris/HCl pH 7.0 
29 ml H2O 
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pellet resuspended in 500 µl 70 % ethanol washing buffer, centrifuged for 30 s at 
13.000 rpm and the supernatant removed. The pellet was washed in the same way 
three more times with ethanol washing buffer.  The last pellet was centrifuged again 
and residual ethanol was removed. 10-20 µl of TE buffer (10 mM Tris/HCl pH 7.5, 0.1 
mM EDTA) were added, incubated for 5 min at 55°C an d centrifuged for 1 min at 
13.000 rpm.  The supernatant was collected and the pellet eluted with another 10-20 
µl TE buffer. The supernatants were combined. 
DNA of Trypanosoma cruzi was a kind gift of Prof. Bernhardt Fleischer, 
Bernhard-Nocht-Institut, Hamburg.  
 
DNA extraction from buffy coat 
2-3 ml of citrate or EDTA-blood were centrifuged for 15 minutes at 1000 x g. 
Then, supernatant plasma was collected and kept in the refrigerator.  The yellow thin 
“buffy coat” layer on top of the sedimented erythrocytes was collected with a pipette 
(200 to 300 µl) and transferred to an Eppendorf tube.  1.2 ml of RBC lysis buffer (300 
mM NH4Cl, 30 mM NH4HCO3, 30 mM KCl. 0.1 mM EDTA) were added, mixed shortly 
by vortexing, incubated 10 minutes at room temperatures, inverting the tube several 
times.  Then, the tube was centrifuged 2 minutes at 2000 x g, and the supernatant 
removed.  A pellet of 10-30 µl was obtained and mixed with DNA extraction buffer. 
DNA was extracted as described above.   
 
2.6  Purification of recombinant Taq DNA polymerase 
Taq DNA polymerase was purified from a recombinant strain of E. coli (E. coli 
XL-1 Blue/pQE-Taq) expressing an exonuclease-free mutant of the enzyme. The 
strain was constructed previously in the laboratory of Prof. E. Beck, University of 
Giessen (unpublished results). The thermostable enzyme can also be purified without 
the cooling steps described in the following protocol.  
1 litre of LB medium containing 25 µg/ml kanamycin and 50 µg/ml ampicillin 
was inoculated with 100 ml of an over night culture of XL-1 Blue pQE-Taq cells.  The 
cells were grown at 37°C with optimal aeration for 1-2 hours.  At an OD600 of 1.8, 1 ml 
of 1 M IPTG was added and then the culture vigorously shaked for another 4 hours.  
Cells were harvested by centrifugation (yield ~5 g) and frozen at -20°C. Freezing of 
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the cells can be omitted, but is recommended if the enzyme preparation is not 
performed immediately.  The cells were resuspended in 15 ml TMN buffer (50 mM 
Tris-HCl pH 8.5, 1 mM EDTA, 20 mM (NH4)2SO4) together with 8 mg of lysozyme 
(from 10 mg/ml stock solution) and incubated for 15 min at 20-25°C.  After adding 
200 µl of 10 % Triton X-100 and 200 µl of 10 % Tween 20, the culture was mixed and 
incubated at 80°C for 20 min in a 50 ml screw-cap F alcon tube.  After the heating 
step, 250 µl of 100 mM PMSF were added to prevent proteolytic degradation. 
DNA was sheared by 1 min sonification (it is also possible to do it by repeated 
pressing through a syringe first with a 1 mm diameter needle and then with smaller 
needles) and centrifuged 15 min at 20.000 x g at 4°C.  The supernatant (~15 ml) was 
collected and 0.6 ml of 5 M NaCl (0.2 M final concentration) were added.  
The DNA was precipitated with polyethyleneimine (PEI) by adding dropwise 
500 µl of 5 % PEI solution, mixing and incubating in ice for 10 min.  The sample was 
centrifuged at 10.000 x g for 5 min.  4 aliquots of 500 µl of supernatant were 
transferred to Eppendorf tubes each and mixed with increasing amounts (2-8 µl) of 5 
% PEI solution.  They were incubated 5 min on ice, centrifuged and the amount of 
pellet compared. The minimal amount of PEI to precipitate DNA quantitatively was 
determinated and added to the bulk extract (usually 100-200 µl; use 1/100 volume of 
5 % PEI solution in excess). The suspension was left 20 min on ice and centrifuged 
at 20.000 x g for 20 min. The supernatant was collected and diluted 6 fold with KTA 
buffer (20 mM Tris/HCl pH 8.5, 10 mM beta-mercaptoethanol, 10 % (w/v) glycerol, 
0.1 mM EDTA, 0.05 % Triton X 100, 0.05 % Tween 20). 
The excess of PEI was removed by passing the extract through a 2 ml BioRex 
70 column equilibrated in KTA buffer + 30 mM ammonium sulphate. A disposable 4 
ml plastic column (International Sorbent Technology, Hengoed, Mid Glamorgan, UK) 
was used.  The column was rinsed with 2 ml KTA buffer and the flow-through loaded 
on another plastic column containing 2 ml heparin sepharose equilibrated with KTA 
buffer, 30 mM ammonium sulphate.  The column was washed first with 50 ml KTA 
buffer, 40 mM ammonium sulphate. Thereafter, the column was washed with 20 ml 
KTA buffer, 40 mM ammonium sulphate, 50 % glycerol. Taq DNA polymerase was 
eluted with KTA buffer, 150 mM ammonium sulphate, 50 % glycerol. 0.5 ml fractions 
were collected and 3 µl aliquots analysed on a 12.5 % SDS polyacrylamide gel.  The 
enzyme was found in fractions 4 to 7. The enzyme was stored at -20°C. For long 
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term storage, Tween 20 to 1 % final concentration was added. The yield was 
approximately 30.000 units of enzyme at a concentration of 80 units/µl in the peak 
fraction. 
 
2.7  Polymerase chain reaction (PCR) 
For all PCR assays, the same Taq DNA polymerase buffer was used. It is 
prepared as a 10 x buffer and has the following composition: 
 
1 x Taq polymerase buffer  
40 mM Tricine-KOH (pH 8.7 at 25°C) 
15 mM K acetate 
3.5 mM acetate 
0.1 % gelatine 
0.05 % Tween 20 
 
 
Standard PCR reaction assay 
Using efficient standard thermocyclers such as T1 thermocycler 96 from 
Biometra, or Primus 96 from MWG Biotech which are appropriate for 200 µl reaction 
tubes, have a heated lid and heating/cooling rates of at least 2-3°C/s, highly 
reproducible results were obtained with assays as small as 10 µl. A standard PCR 
reaction mixture had the following composition: 
 
1 µl 10 x Taq buffer 
1 µl mixture of 4 dNTPs (2.5 mM each)  
0.5 µl 10 µM forward primer 
0.5 µl 10 µM reverse primer 
1 µl template DNA  
5.8 µl H2O 
0.2 µl Taq DNA polymerase (5 units/µl) 
10.0 µl 
 
10 x Taq polymerase buffer (10 ml) 
4 ml 1 M Tricine-KOH 
1.5 ml 1 M K acetate 
350 µl 1 M acetate 
2.5 ml 4 % heated gelatine solution  
500 µl Tween 20 
1.15 ml H2O 
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The standard program of the thermocycler was set as follows: 
step 1:    2 min at 94°C (denaturing of DNA templat e) 
step 2:    35 cycles of [94°C for 20 s, 60°C for 1 min, 72°C for 1 min] 
step 3:    5 min at 72°C (optional, to fill-in the DNA ends completely) 
 
The same conditions were applied for nested PCR. 1 µl of a 1:10 dilution (with 
H2O) of the result of first PCR assay was used as DNA template. 
 
Avoiding contamination 
The sensitivity of PCR diagnosis is very high. Theoretically DNA from less 
than one parasite can be detected. This implied a high risk for contamination, which 
had to be strictly avoided. As a general rule, the extraction of DNA, the preparation of 
the PCR and electrophoresis of the PCR products should be strictly separated. It is 
also recommended to use different sets of pipettes for the different parts of the work. 
Due to limitations of space and technical equipment this standard could not always 
be met. Instead, extra precautions had to be taken. 
• DNA extraction from clinical material and preparation of the PCR was 
performed in a hood, located in a small room separated from the rest of 
the laboratory. PCR-cycling and gel electrophoresis were performed on 
an extra bench. 
• All solutions used for DNA extractions were divided in small aliquots 
from a stock solution and discarded in case of a suspected 
contamination 
• An extra pipette (“dirty pipette”) was used exclusively for loading of the 
gels with the higly amplified PCR products.  
• Filter tips were used for DNA extraction and for all pipetting steps for 
PCR. 
• Gloves were changed during the procedures from time to time. 
• The rotor of the micro-centrifuge was washed prior to DNA extractions 
since the tops of the 1.5 ml tubes came in contact with the upper 
margin of the cups holding the tubes. Since also highly amplified DNA 
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was centrifuged in the same centrifuge, these cups were assumed to be 
a source of contamination. 
• Whenever possible 200 µl tips were used instead of 10 µl tips. Due to 
the length of the 200 µl tips the shaft of the pipette could not touch the 
1.5 ml tubes from inside.  
Negative controls 
The extraction of DNA as well as the PCR had to be monitored strictly for 
possible cntamination. Two negative extraction controls were routinely used for every 
extraction series. The PCR itself was monitored by one reaction in every PCR, which 
contained only the reagents and no template. 
 
 
2.8  DNA gel electrophoresis 
 
Agarose gel electrophoresis buffer (E-buffer)  
40 mM Tris/acetate (pH 8,0)  
40 mM Na acetate 
2.0 mM EDTA 
 
 
 
 
Acrylamide gel electrophoresis buffer (TBE-buffer) 
90 mM Tris/borate pH 8.3  
2.5 mM EDTA 
 
 
 
 
20 x E-buffer 
193.8 g Tris-base 
131.2 g Na acetate 
160 ml 0.5 M EDTA 
adjust pH 8.3 with acetic acid 
add H2O to 2 litre 
10 x TBE-buffer  
108 g Tris-OH 
55 g boric acid 
40 ml 0.5M EDTA  
adjust pH 8.0 with acetic acid 
add H2O to 1 litre 
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Loading buffer 
20 mM Tris/HCl pH 7.5  
50 % glycerol  
0.02 % bromphenol blue  
0.02 % xylene cyanol blue  
20 mM EDTA 
 
Ethidium bromide staining solution 
1 µg ethidium bromide / 100 ml E-buffer 
 
 
DNA size marker 
: 
 
 
 
 
 
 
 
 
 
 
Agarose gels 
Agarose gel electrophoresis was performed according to standard procedures 
(Sambrook et al. 1989).  Plasmid DNA and PCR fragments were analysed on 
horizontal 1 % or 2 % agarose gels using a Tris/acetate electrophoresis buffer  
(E-buffer).  To check migration of the DNA fragments, the samples were mixed with 
20 % loading buffer containing 50 % glycerol and marker dyes. In 1 % agarose gels, 
Loading buffer 
0.2 ml 1 M Tris/HCl pH 7.5 
5 ml glycerol 
0.2 ml 10 mg/ml bromphenol 
blue 
0.2 ml 10 mg/ml xylene 
cyanol blue 
0.4 ml 0.5 M EDTA 
Staining solution 
400 ml 1 x E-buffer 
40 µl 10 mg/ml ethidium 
bromide solution 
2999 
2288 
 
1198 
 
692 
517 
 
354 
396 
 
 
218 
 
176 
 
 
 
 
 
75 
65 
Plasmid pSP 64 was cleaved a) with Hind III, b) with 
Dra I and c) with Hinf I. The individual cleavage 
assays were mixed in the relation 1:2:4 with respect 
to the amount of plasmid DNA, resulting in the 
fragment sizes indicated in the figure (in basepairs) 
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bromphenol blue migrates at the position of 200 bp, whereas xylenecyanol blue 
migrates at the position of 300 bp.  The gels were stained for 20 min with ethidium 
bromide staining solution.  Then they were rinsed with tape water, the DNA bands 
visualised on an UV transilluminator and photographed by a Polaroid camera. 
Alternatively, a simple digital camera in combination with a yellow filter was used.  
 
Polyacrylamide gels 
For the analysis of proteins, discontinuous polyacrylamide gels (10 x 8 x 0.1 
cm) containing SDS (Lämmli, 1970) were prepared in different concentrations 
according to the following recipe:  
 
    Stacking gel      Separating gel  
                    10 ml      16 ml       16 ml 
 
 
Stacking gel buffer: 
125 mM Tris-HCl (pH 6.8) 
0.1 % SDS 
 
 
Separating gel buffer: 
375 mM Tris-HCl (pH 8.8)  
0.1 % SDS 
 
 6 % 12,5 % 15 % 
40 % Acrylamide /  
1.3 % bisacrylamide solution  
1,5 ml 5,0 ml 6,0 ml 
4 x buffer 2,5 ml 4,0 ml 4,0 ml 
H2O 6,0 ml 7,0 ml 6,0 ml 
Ammonium persulphate 10 µg 10 µg 10 µg 
TEMED  15 µl 20 µl 20 µl 
    
4 x Stacking gel buffer 
12.14g Tris-OH 
8 ml 10% SDS  
adjust pH 6.8 with HCl (~8 ml HCl 37%) 
add H2O to 200 ml 
4 x Separating gel buffer  
45.43 g Tris-OH 
10 ml 10% SDS  
adjust pH 8.8 with HCl (~6 ml HCl 37 %) 
add H2O to 250 ml 
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3 RESULTS 
3.1  Evaluation of epidemiological data on leishmaniasis in Yemen 
Official data on the prevalence rate of leishmaniasis in Yemen have been 
obtained from the Ministry of Health and from the Office of Surveillance of Disease in 
the capital Sana’a. However, these data have to be regarded with care, as they 
include only infections reported from governmental hospitals, the two biggest ones 
located in Sana’a and Taizz. Much of the medical treatment for the population is 
managed in private clinics, or by non-governmental organisations which do not report 
to the central administration of the country. Furthermore, in the absence of any 
support for health care, poor people do not seek medical aid for small wounds such 
as the ulcers of cutaneous leishmaniasis. Therefore, the real number of Leishmania 
infections is most probably by far higher than officially documented. The data 
obtained from the Ministry of health for the years 2005 to 2008 are shown in Table 4.   
 
Table 4 :Leishmaniasis in the diferent governates of Yemen in 2005-2008 
2005 
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l 
number of 
patients 58 0 15 247 0 279 5 1 62 0 18 90 19 12 4 53 13 16 10 17 72 991 
male 40 0 12 201 0 240 5 1 45 0 14 75 14 8 4 45 10 12 7 12 60 805 
female 18 0 3 46 0 39 0 0 7 0 4 15 5 4 0 8 3 4 3 5 12 176 
cutaneous 
leishmaniasis 55 0 14 227 0 249 5 1 60 0 18 90 19 11 4 51 13 16 9 17 65 924 
visceral 
leishmaniasis 
3 0 1 20 0 0 0 0 2 0 0 0 0 1 0 2 0 0 1 0 7 37 
 
2006 
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number of 
patients 642   0 81 230 0 153 12 5 76 44 5 242 91 57 85 130 43 3 0 17 54 1970 
male 480 0 60 160 0 96 7 0 46 27 5 220 72 45 70 110 37 3 0 12 45 1495 
female 162 0 21 70 0 57 5 5 30 17 0 22 19 12 15 20 6 0 0 5 9 475 
cutaneous 
leishmaniasis 605 0 77 220 0 153 12 5 70 44 5 242 91 57 85 125 43 3 0 12 50 1899 
visceral 
leishmaniasis 
37 0 4 10 0 0 0 0 6 0 0 0 0 0 0 5 0 0 0 0 4 66 
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Table 4 continued 
2007 
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number of 
patients 65 1 51 343 0 74 15 1 44 9 2 20 89 61 37 303 31 0 4 0 29 1179 
male 55 1 47 320 0 65 12 1 35 6 2 16 81 55 33 370 28 0 4 0 25 1156 
female 10 0 4 23 0 9 3 0 9 3 0 4 8 6 4 33 3 0 0 0 4 123 
cutaneous 
leishmaniasis 58 1 48 327 0 74 15 1 44 9 2 20 89 58 37 293 31 0 4 0 26 1137 
visceral 
leishmaniasis 
7 0 3 16 0 0 0 0 0 0 0 0 0 3 0 10 0 0 0 0 3 42 
 
2008 
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number of 
patients 70 0 6 367 2 120 13 7 32 0 7 25 89 40 110 105 0 5 85 32 45 1160 
male 62 0 4 350 2 109 10 6 24 0 5 22 81 32 98 92 0 5 78 25 35 1040 
female 8 0 2 17 0 11 3 1 8 0 2 3 8 8 12 13 0 0 7 7 10 120 
cutaneous 
leishmaniasis 60 0 5 355 2 120 13 7 32 0 7 25 89 35 110 105 0 5 82 32 36 1120 
visceral 
leishmaniasis 
10 0 1 12 0 0 0 0 0 0 0 0 0 5 0 0 0 0 3 0 9 40 
 
__________________________________________________________________________ 
 
Figure 7: Distribution of Leishmaniasis in the different governates of Yemen 
Cutaneous leishmaniasis Visceral leishmaniasis 
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The location of the different governates and the distribution of leishmaniasis as 
listed in Table 3 is shown in Figure 7. Even though the information on leishmaniasis 
is limited and the actual incidence of the disease is probably much higher, some 
intersting conclusions can be drawn from these data. One aspect is the relation 
between the cutaneous and the visceral form of the disease. Only 3.3 % of the 
infected patients suffer from visceral leishmaniasis whereas the majority of cases 
correspond to the cutaneous form of the disease as graphically shown  in Figure 7.  
The relation of female patients versus male patients is also striking and differs 
markedly form other endemic countries where there is no difference between the 
genders. This may be explained by the fact that traditionally women protect their 
bodies – including the face - completely with clothes when they are outside of doors, 
whereas men are less covered and can be easier be attacked by sand flies. The 
major sites of ulcers due to Leishmania are typically face and legs (see Figure 8). 
Another explanation is the shyness of women to visit male doctors, and there are 
very few female doctors in the country.  
 
 
     Figure 8: Frequency of leishmaniasis in Yemen during the years 2005 – 2008 
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Figure 9: Cutaneous leishmaniasis. Typical sites of ulcers are face and legs which are 
usually most exposed to bite of sandflies. 
 
Another interesting aspect is the number of cases of leishmaniasis during the 
different years. In 2006, there was a high increase of the disease as compared to the 
other years. This may be explained by the climate, more specifically by the amount of 
rainfall which is needed for breeding of the phlebotomine vectors. There are no 
measures to control sandflies in Yemen. 
 
 
          
 
 
 
 
Figure 10: Monthly distribution of leishmaniasis Rimah (Western Yemen) 
In the fertile areas in the western part of Yemen, the majority of patients with 
leishmaniasis are registerd in the middle of summer as exemplified by  Figures 10and 
11. 
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Figure 11: Monthly distribution of leishmaniasis Haija (Western Yemen) 
 
In the arid region in the eastern governates, the majority of cases occurs 
between January and March (Figure 12). This area is extremely hot im summer time 
and there is almost no rain. The vectors can only develop during the cooler winter 
season, and water exists only in so called wadis, deep canyons which carry some 
water from the mountains only part of the year. 
 
 
 
 
 
 
 
 
Figure 12: Monthly distribution of leishmaniasis in Hadramont (Eastern Yemen) 
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3.2  Collecting samples of leishmaniasis patients in Yemen 
In order to obtain more data on the epidemiology of leishmaniasis and to 
collect material for future attempts to develop a new, inexpensive, but highly specific 
diagnostical procedure, blood samples from patients with suspected leishmaniasis 
were collected in several locations in the western part of Yemen. The differential 
diagnosis was generally done based on history of exposure (sandfly bites) and 
physical examination focussed on ulceric lesions and scar formation. Whenever 
possible, scrapings from open ulcers were analysed by microscpopy upon Giemsa 
staining in order to detect amastigote parasites inside of infected cells (see Figure 1). 
In suspected cases of visceral leishmaniasis, involvement of internal organs was 
analysed by palpating liver and spleen.  
The blood samples were immediately mixed with EDTA (10 mM final 
concentration) and centrifuged with a manual centrifuge (Roth, Karlsruhe, Germany) 
in order to sediment the blood cells (Figure 13).  
 
 
 
 
 
 
 
 
 
Figure 13: Manual centrifuge used to prepare plasma and buffy coat from blood 
samples under field condition 
 
The supernatant plasma was withdrawn and mixed with one volume of 
glycerol. The yellow layer on top of the sedimented erythrocytes (buffy coat, 
consisting mainly of white blood cells and platelets) was collected with a pipette and 
mixed with one volume of 5 M guanidinium hydrochloride dissolved in 20 mM Tris 
buffer pH 7.5 and 50 mM EDTA. By this way, the plasma as well as the DNA were 
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conserved and could be kept at ambient temperature for several weeks without to be 
damaged. The samples were transported to Germany for detailed laboratory 
diagnosis (see below). They served as a basis for developing new diagnostic assays, 
the plasma for an immunoassay with recombinant antigens (doctoral thesis of 
Michael Heiman in our group), and the DNA after extraction from the buffy coat for 
developing new PCR assays as described below.  
In addition to patients with open wounds characteristic for cutaneous 
leishmaniasis, 26 samples were collected from hospitalized persons suspected to 
have the visceral form of disease. Typical symptoms of visceral leishmaniasis are 
general weakness, a swollen abdomen (Figure 14) and low counts of white blood 
cells. Normally, such persons have no cutaneous wounds, but are hospitalized 
because of their weakness. In the absence of good immunological tests, correct 
diagnosis is very difficult. In Yemen, a formalin precipitation test is being used (see 
Materials and Methods), but this test has a low specificity. This test is being used to 
detect the greatly increased serum proteins in visceral leishmaniasis; one drop of 
concentrated formalin is added to 1 ml of serum, with rapid and complete coagulation 
indicating the positive reaction. The parasites could be found microscopically in 
biopsies from liver or bone marrow, but this test is not performed in Yemen. Blood 
samples from these persons were collected and processed as described above. 
 
 
 
 
 
 
 
 
 
 Figure 14: Visceral leishmaniasis 
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3.3  Laboratory diagnosis of the collected patient samples in Yemen 
After collection, samples were taken for laboratory confirmation of 
leishmaniasis. Basically, there are four major categories of diagnostic methods used 
routinely: Parasitological methods (for the detection of amastigotes in Giemsa-
stained smears of scrapings from the wound, aspirates of bone marrow or lymph 
nodes), in vitro cultivation, immunological tests such as the enzyme-linked 
immunosorbent assay (ELISA), and molecular methods (polymerase chain reaction, 
PCR). In Yemen, only microscopical analysis was performed. 
Scrapings from the wounds of all 119 patients suspected of having cutaneous 
leishmaniasis were analysed by microscopical examination in the International 
Central Blood Bank in Sana’a, Yemen during the years 2005-2006. According to this 
analysis, 47 of the patients (39 %) were found to be positive. 25 patients were male 
(53%) and 22 were female (47%). The majority of the positive persons were in the 
age group 15-34 years (55%). The age group less than 15 years was represented by 
14 patients (30%). The highest prevalence rate of disease (74%) was seen in 
patients comming from rural areas.  
It is well known that microscopical analysis has a sensitivity of maximal 70 % 
only (Al-Jawabreh, 2008), i.e. at least one third of the actual infections could not be 
confirmed by this way. Furthermore, it is not possible to discriminate different species 
of Leishmania by microscopy. Several of the cases characterized as cutaneous 
leishmaniasis could have been caused by L. infantum and would correspond to 
visceral leishmaniasis. The samples from the suspected visceral leishmaniasis 
patients were no futher alanlysed in Yemen. The samples of all patients were 
transported to the laboratory in Giessen for further analysis. 
 
3.4  Establishing new procedures for the diagnosis of leishmaniasis  
Commercially available diagnostic test kits for leishmaniasis are very 
expensive and not affordable under the social and economical conditions of Yemen. 
In addition, Leishmania strains differ markedly in geographical regions of the world so 
that tests developed elswhere may not function sufficiently in the country (Burns et 
al., 1993; Jensen et al., 1999; Kumar et al., 2001; Maalei et al., 2003: Boarino et al., 
2005; Chappuis et al., 2005). Appropriate diagnostic procedures should be highly 
sensitive and specific, but at the same time inexpensive and simply to perform. Two 
39 
 
 
different approaches to this problem were attemptet in our group in parallel, one 
included immunoassays with recombinant antigens (Heimann, 2008), and the other, 
which is topic of this thesis, included molecular methods. PCR is very useful for 
diagnosis, as it is highly sensitive and specific and can be performed with many 
different biological samples including skin scrapings, blood or enriched leukocytes 
and biopsy material such as liver or bone marrow. In addition, PCR diagnosis can be 
made highly specific and more sensitive than immunological methods. In any case, it 
is always recommended to use more than one diagnostic test.  
To obtain sufficient DNA in pure form to establish PCR assays, two laboratory 
strains of the parasite, L. major and L. infantum, were cultivated in tissue culture 
medium (medium 199 or earle’s medium) supplemented with glutamine and fetal calf 
serum each at 26 °C for at least two weeks as descr ibed in the Materials and 
Methods section. Growth of the promastigotes was observed by microscopy. DNA 
was extracted by the guanidinium silica procedure. Aliquots of the purified DNA were 
kept at -20°C and used to set up PCR assays with di fferent sets of primers. 
 
3.5  Establishing new diagnostic PCR procedures  
To establish diagnosis of leishmaniasis with PCR, several genes of 
Leishmania have been identified, preferentially targets with multiple copies, for 
example kinetoplast DNA (kDNA), ribosomal RNA genes (rRNA), mini-exon-derived 
RNAs (medRNA) and multiple repeats in protein coding genomic regions. Leishmania 
is member of the order kinetoplastida, a group of organisms possessing a unique 
organelle, the kinetoplast, which is a single mitochondrion containing a characteristic 
DNA structure known as the kinetoplast DNA network. Kinetoplast DNA comprises 
two components, maxicircle and minicircle kDNA. Maxicircles, 20.000 - 40.000 
basepairs (bp) in length, are present in 30 - 50 copies and carry the genes encoding 
the mitochondrial enzymes. Minicircles are approximately 1000 bp in length, they 
encode guide RNA (gRNA) molecules involved in the RNA editing of maxicircle 
cryptogenes and are present in 10.000 – 20.000 copies per parasite. Because of the 
high copy number of the minicircles, the kDNA is a prefered target, even though 
these plasmid-like elements are not fully homogenous, but contain variable sizes and 
sequences. However, all minicircles contain two highly conserved sequences of 23 
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and 26 nucleotides which are localized in a distance of approximately 120 bp from 
each other. Primers directed to these conserved regions can be used to detect all 
Leishmania species. Because the distance between these conserved regions are 
somewhat variable amongst the different minicircle species, the resulting PCR 
fragment looks sometimes slightly diffuse. In addition, the small size of the resulting 
fragment cannot be analysed easily by agarose gel electrophoresis. Nevertheless, 
there is no comparable highly amplified sequence in the genome of the parasite and 
kDNA-specific primers have been used by several groups for specific PCR diagnosis 
of leishmaniasis (Singh et al., 1999; Disch et al., 2005 Reithinger and Dujardin, 
Bensoussan et al., 2006; 2007; Gomes et al., 2008). A limitation of this highly 
sensitive test is that it cannot be used to discriminate between different species of 
Leishmania.  
Another widely used target are the approximately 200 copies of ribosomal 
genes distributed in the different chomosomes of Leishmania. Preferntially used by 
many groups is the coding sequence of the 18S small ribosomal RNA gene (Van Eys 
et al., 1992; Wortmann et al., 2001; Schönian et al., 2003). This sequence has been 
determined for more than hundred isolates of different leishmania strains and is 
highly conserved. At the other hand, this sequence is distant enough from closely 
related species such as Trypanosoma cruzi and Trypanosoma tarantolae which both 
occur in areas of South America in parallel to Leishmania and may even co-infect the 
patients. As with the kDNA, discrimination between different Leishmania species is 
not feasible, however, specific PCR fragments of 400 to 600 bp can obtained which 
allow perfect resolution on agarose gels. The disadvantage of a lower copy number 
can easily be compensated by nested PCR with a second set of primers, although 
this is not needed in most cases. 
To obtain PCR assays which discriminate between different Leishmania 
strains, repetitive sequences specific for individual Leishmania species were 
selected. As the former sequences, this information was extracted from the complete 
genomic sequences of L. major and L. infantum as contained in the Sanger gene 
data base (GeneDB) (http://www.genedb.org/genedb/leish/index.jsp and  
http://www.genedb.org/genedb/linfantum) which is freely available in the internet. 
These sequences consist of approximately 100 million bp each and can be handled 
only by using appropriate computer software programs. One of these programs is the 
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“Tandem Repeats Finder” (http://tandem.bu.edu/trf/trf.html) which allows to analyse a 
whole chromosome (1-2 million bp) of Leishmania at once. Large parts of the 
genomes consits of tandem repeats with lengths between 15 to several hundred bp 
and it was attempted to find repetitions which were firstly specific for either L.major, 
or for L. infantum and secondly of a size easily to be analysed by agarose gel 
electrophoresis. Two of such sites were selected for designing PCR primers. As the 
sequences were arranged in mutiple copies as tandem arrays, the resulting PCR 
product was not a single band, but rather a ladder of fragments corresponding to 
one, two or more repeats of such sequences. In the following, the design of specific 
primers for PCR amplification of the above target sites are described. Altogether, four 
different PCR assays were developed and tested, two of them turned out to be highly 
useful for diagnosis of Leishmaniasis. 
 
3.5.1  Kinetoplast minicircle (kDNA) specific PCR 
In order to define regions in the kDNA appropriate for PCR primer design, a 
number of representative DNA sequences of relevant Leishmania strains were 
selected from data bases and aligned by means of the software ClustalW 
(http://www.ch.embnet.org/software/ClustalW.html).  This alignment is shown in 
Figure 10. Only the most conserved part of the corresponding kDNAs are depicted. 
Nucleotides identical in all sequences are indicated by an asterix below the lines. As 
can be seen, only two sequences represent common regions with sufficient length for 
primer design. The sequence marked in blue was chosen as forward primer 
(Leishmini-F, ATTTTACACCAACCCCCAGTT) and the sequence marked in blue as 
reverse primer (Leishmini-R, GGG(G/T)AGGGGCGTTCTGC). The calculated 
annealing temperature for both primers is the same (approximately 60°C) which is 
essential for optimal PCR results. The reverse primer contains in position 4 a mixture 
of the nucleotides G and T in order to match the kDNA sequence of all Leishmania 
species.  
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Multiple alignment of Leishmania spp minicircle DNA genes 
 
L.donovani          CACCCCACACCGCCTATTTTACACCAACCCCCAGTTTCCACCGCCGGAGCCCGGGATT-- 
L amazon.complex    CCACGCACCGGG--TATTTTACACCAACCCCCAGTTGTGACCGCCGGAG-CCGGAATTC- 
L mexicana complex  GAGACCCCCGCCGCTATTTTACACCAACCCCCAGTTTCGAGCCCGGGAG-CCGATTTTCG 
L infantum          GGACCACCCGGCCCTATTTTACACCAACCCCCAGTTTCCCGCCCCGGAGGCCAAAAATG- 
L.tropica complex   GGACCACCCCCACCTATTTTACACCAACCCCCAGTTTGCAGCCTCCGAGCCCAAAAATG- 
L.major complex     GGACCCACCCGGCCTATTTTACACCAACCCCCAGTTTGCACGCCCCGAGGCCAAAAATG- 
                       . ..*.     **********************   .      *** **.. ::*   
 
L donovani          ----------TTTGCCCAAAATATGAACGG-GGTTTCTGCACTCATTTTTCCCAAAATCG 
L.amazon.complex    ----CCCAAAATTCCCCAAAATATGAACGG-GGTTTCTGCACTCATTTTTCCCAAATTCG 
L.mexicana complex  AGGAATTCGAATTCCCCAAAATATGAACGG-GGTTTCTGCACTCATTTTTGCCCTCCCCG 
L.infantum          -----ACATTTTCGGGCCAAAAATGAACGGGAATTTCTGCACCCATTTTT-CGGTTTTCG 
L tropica complex   ----GCATTTTTTCAGG-ATTTTTGAACGG-GGTTTCTG-TATCAATTTTCGCGATTTTG 
L.major complex     ----GCCATTTTCCGTGGATTTTTGAACGG-GGTTTCTG-TATCGATTTTTCGAAATTCG 
                              :*      *::::******* ..****** :. *.:****    :    * 
 
L donovani          CAGAACGCCCCTCCCCCACGGGGCAG-AAAAGTTTGGATTTCTGGCCCATTTTTTGCCAC 
L.amazon.complex    CAGAACGCCCCTCCCCCACGGGGCAGAAAAGTTTGGG----------------------- 
L.mexicana complex  CAGAACGCCCCTCCCCCACGG--CAGAAAAGTTTGGAATTCTGGCCATTTTTGACCCCAT 
L.infantum          CAGAACGCCCCTCCCCCACGGACCAGAAAAGTTTGGATTTTTAGGCCATTTTTTGGGATT 
L.tropica complex   CAGAACGCCCCTACCCGGAG--CTACTCCATGTTTGGAAATTC-CCCCATTTTTGGCCAT 
L.major complex     CAGAACGCCCCTACCCGGAGGGCTACTCCATGCTACGATTTCTGCCCCTTTTTTGACGAA 
                    ************.*** ..*    *  ..*   *  .                        
 
 
Figure 15: Alignment of the conserved kDNA regions of representative Leishmania strains. 
Complex means a number of geographically distinct strains showing the same sequence. 
The sequences marked in blue and red were selected to design PCR primers.   
 
Tests with purified DNA from the cultivated strains L. major and L. infantum led 
to the expected product of approximately 120 bp by electrophoresis on 6 % 
polyacrylamide gels (Figure 16). However, using this set of primers in PCR with DNA 
extracted from buffy coats, no band was detectable in the majority of cases. Only 
when the PCR was repeated by using 1 microliter of first PCR product as a template 
and the same set of primers again, the expected band became visible.  
 
  
 
 
Figure 16: Analysis of Leishmania kDNA PCR products on 6 % polyacrylamide gels.  DNA 
was extracted from buffy coat samples of patients number 50
leishmaniasis). m = size marker, Lm = 
control,  C = water instead of DNA as a negative control. 
 
3.5.2 18S rRNA specific PCR
In principle, the results with kDNA
sensitive and specific, however, the small size of the resulting fragment demands the 
use of polyacrylamide gels for resolution which makes handling of large numbers of 
samples demanding. Therefore, the gene for the 18S ribosomal RNA was selected 
as an alternative target for s
identical copies in the genome of 
highly related form and probably in similar numbers in other 
has been used as a target for PCR diagnosis by several groups already using 
different sets of primers. However, these pri
of Old World Leishmania 
Leishmania species from Trypanosoma cruzi, the agent of Chagas disease,
occurs in Latin America in regions endemic for both, 
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-specific PCR appeared to be sufficiently 
pecific PCR. The gene occurs in approximately 160 
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                               I--Leish18S-out-F--> 
L. tarentolae     AGAAATAGAGTTGTCAGTCCATTTGGATTGTCATTT-CAATGGGGGATATTTAAACCCAT  
L. donovani       AGAAATAGAGTTGTCAGTCCATTTGGATTGTCATTT-CAATGGGGGATATTTAAACCCAT  
L. amazonensis    AGAAATAGAGTTGTCAGTCCATTTGGATTGTCATTT-CAATGGGGGATATTTAAACCCAT  
L. major          AGAAATAGAGTTGTCAGTCCATTTGGATTGTCATTT-CAATGGGGGATATTTAAACCCAT  
T. cruzi          AGAAATAGAGCCGACAGTGCTTTTGCATTGTCGTTTTCAATGGGGGATATTTAAACCCAT  
                  **********  * **** * **** ****** *** *********************** 
// 100 nucleotides // 
 
                                      I--Leish18S-inn-F--> 
L. tarentolae     TAGTTGAACTGTGGGCTGTGCAGGTTTGTCCCTGGTCGTCCCGTCCATGTCGGATTTGGT  
L. donovani       TAGTTGAACTGTGGGCTGTGCAGGTTTGTTCCTGGTCGTCCCGTCCATGTCGGATTTGGT  
L. amazonensis    TAGTTGAACTGTGGGCTGTGCAGGTTTGTTCCTGGTCGTCCCGTCCATGTCGGATTTGGT  
L. major          TAGTTGAACTGTGGGCTGTGCAGGTTTGTTCCTGGTCGTCCCGTCCATGTCGGATTTGGT  
T. cruzi          TAGTTGAATTGAGGGCCTCTAAGGCGCAATGGTT-TAGTCCCATCCACTTCGGATT-GGT  
                  ******** ** ****     ***        *  * ***** ****  ******* ***  
// 380 nucleotides // 
 
                          <---------Leish18S-inn-R-------------I 
L. tarentolae     TCGTCCGGCCGTA----------------ACGCCTTT--TCAACTCACGGCCTCTAGGAA  
L. donovani       TCGTCCGGCCGTA----------------ACGCCTTT--TCAACTCACGGCCTCTAGGAA  
L. amazonensis    TCGTCCGGCCGTA----------------ACGCCTTT--TCAACTCACGGCCTCTAGGAA  
L. major          TCGTCCGGCCGTA----------------ACGCCTTT--TCAACTCACGGCCTCTAGGAA  
T. cruzi          CTTGCC-TCCGCATATTTTCACATGTGTCATGCCTTCCCTCAACTCACGGCATCCAGGAA  
                      **   ** *                * *****   ************ ** ***** 
 
                             <--Leish18S-out-R--I 
L. tarentolae     TGAAGGAGGGTAGTTCGGGGGAGAACGTACTGGGGCGTCAGAGGTGAAATTCTTAGACCG  
L. donovani       TGAAGGAGGGTAGTTCGGGGGAGAACGTACTGGGGCGTCAGAGGTGAAATTCTTAGACCG  
L. amazonensis    TGAAGGAGGGTAGTTCGGGGGAGAACGTACTGGGGCGTCAGAGGTGAAATTCTTAGACCG  
L. major          TGAAGGAGGGTAGTTCGGGGGAGAACGTACTGGGGCGTCAGAGGTGAAATTCTTAGACCG  
T. cruzi          TGAAGGAGGGTAGTTCGGGGGAGAACGTACTGGTGCGTCAGAGGTGAAATTCTTAGACCG  
                  ************************************************************  
 
 
Figure 17: Alignment of part of 18S rRNA genes of different Leishmania strains with the 
corresponding sequence of T. cruzi. The complete genes consist of approximately 2200 bp 
each, however, only the central part (some 600 bp) for most of these sequences is known 
and was aligned. Regions highly conserved between Leishmania and T. cruzi have been 
ommitted (100 nucleotides in the first third, and 380 nucleotides in the middle of the 
sequence). The locations of the inner (blue) and outer PCR primers (red) are indicated. 
 
PCR primers were selected based on the nucleotide sequence of L. major as 
template. It was attempted to select primers in regions clearly different between 
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Leishmania and T. cruzi. However, only two such regions existed as shown in the 
above alignment. They were used to design optimal primers with help of the primer 
seach program “Primer3” (http://frodo.wi.mit.edu/). The resulting PCR fragment was 
335 bp. Since it was to be expected that like in the case of kDNA a second PCR 
would be needed to obtain visible bands upon gel electrophoresis, another set of 
primers was selected with the same software. As the above PCR product was 
relatively short, so called “outer” primers were searched in the flanking region of the 
18S rRNA sequence. There was no chance to find another set of primers which 
would discriminate Leishmania and T. cruzi, sequences with optimal physical 
characteristics were chosen (Primer3 includes more than 20 different criteria for 
optimising primers, such as the content of CG versus AT nucleotides, potential 
hairpin structures, annealing temperature, stability of the hybrid at 3’ and 5’ ends 
etc.). The outer primers discriminater clearly between Leishmania and other 
organisms including men (not shown), but they cannot well discriminate between 
Leishmania and T. cruzi. The reverse primer hybridizes to the identical sequence in 
both species, for the forward primer there are five base exchanges, at least, They 
would be sufficient under stringent conditions, however, under such conditions the 
amplification of DNA is reduced thus reducing the sensitivity of the assay. As a 
compromise, one would accept limited specificity in the first PCR using the outer 
primers, and use part of the amplification product as template for the second, clearly 
discriminatory second PCR. The location of inner and outer primers are indicated in 
Figure 17.  
These primers were used to analyse the DNA extracted from the buffy coat 
frction of 63 blood samples from Yemenit patients suspected to have cutaneous 
leishmaniasis. As the expected PCR fragments were 480 bp (outer primers) or 335 
bp long (inner primers), 2 % agarose gels could be used simplifying markedly the 
analysis of results.  As can be seen from from the upper halfs of the gels shown in 
Figure 15, except of the positive control with purified L. major DNA, only in rare cases 
(in numbers 9 and 12) a weak band was visible at position 480 upon staining the gels 
with ethidiumbromide.  However, in the second PCR shown in he lower halfs of the 
gels, clear-cut positive results were obtained with the majority of samples, whereas 
other samples were clearly negative. 
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Figure 18. PCR amplification of buffy coat sample obtained from patients with cutaneous 
leishmaniasis by 18S rRNA-specific primers. m = size marker,  Lm = Leishmania major purified DNA 
as positive control,  and C = water as negative control. 
 
 
The results with the 18S rRNA specific PCR were consistent with the results obtained 
with the kDNA specific PCR except of three samples (numbers 50, 51 and 61) which 
were positive in the latter assay, but negative with the 18S rRNA PCR. This could be 
explained by the fact, that the kDNA-specific PCR is more sensitive (see Discussion 
section). 
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3.5.3  45 basepair repeat-specific PCR 
As another approach to a sensitive molecular assay, the amplification of a 
45 bp repeat was attempted. Analysis of the genome of L. major with Tandem 
Repeats Finder software (http://tandem.bu.edu/trf/trf.html) revealed that this repeat 
occurred in more than 1000 copies in the genome. The sequence exists in identical 
form and almost the same frequency also in L. infantum, but does not occure in 
Trypanosoma cruzi. It is spread in ten different arrays of 7 to more than 200 repeats 
over the whole genome.  A section of 4 of these repetitive sequence was used to 
select optimal PCR primers with the computer program Primer3 as shown in Figure 
16. The primers were named Leish45-F and Leish45-R. 
 
 
OLIGO            start  len      tm     gc%   any    3' seq  
LEFT PRIMER          9   17   61.96   70.59  6.00  1.00 CGGAGCTGCTGCTGGAC 
RIGHT PRIMER       181   17   61.65   70.59  3.00  1.00 GGCGTCCTCGTCGTCTG 
SEQUENCE SIZE: 225 
INCLUDED REGION SIZE: 225 
 
PRODUCT SIZE: 173, PAIR ANY COMPL: 4.00, PAIR 3' COMPL: 1.00 
 
    1 CGACGGCGCGGAGCTGCTGCTGGACGGCGCAGACGACGAGGACGCCGACGGCGCGGAGCT 
              >>>>>>>>>>>>>>>>>                                    
 
   61 GCTGCTGGACGGCGCAGACGACGAGGACGCCGACGGCGCGGAGCTGCTGCTGGACGGCGC 
                                                                   
 
  121 AGACGACGAGGACGCCGACGGCGCGGAGCTGCTGCTGGACGGCGCAGACGACGAGGACGC 
                                                  <<<<<<<<<<<<<<<< 
 
  181 CGACGGCGCGGAGCTGCTGCTGGACGGCGCAGACGACGAGGACGC 
 
Figure 19: Result of the search for an optimal set of PCR primers for the 45 bp repeat of L. major 
using the computer program Primer3. The program was asked for optimal primers producing 
fragments in a length between 150 and 200 bp on the basis of 4 copies of the repeated sequence. For 
easier visualisation, the predicted forward and reverse primers have been marked in red and blue. As 
the sequence is repetitive, each primer occurs for times. The sequence of the recommended right 
primer (blue) as shown in the upper part of the figure is present in complementary form in the 225 
nucleotide sequence which corresponds to the positive DNA strand. Amongst others, the program also 
indicates the calculated optimal annealing temperature (tm) for each primer. 
 
Because the sequence is repetitive, hybridisation sites for the primers occur 
every 45 bp in the plus strand as well as in the minus strand of DNA. This leads to 
the production of not only one PCR product, but to a characteristic ladder of bands 
differing by the length of 45 bp from each other. Testing these primers in a PCR with 
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purified DNAs of L. major and L. infantum resulted in exactly this predicted pattern of 
DNA bands (Figure 20). 
 
 
 
 
 
 
 
 
 
 
Figure 20: Amplification products obtained with the primers Leish45-F and Leish45-R on a 6 % 
polyacrylamide gel. In the first two lanes, template DNA is from purified parasites. Lanes 1-6 show 
results with DNA extracted from buffy coat of cutaneous leishmaniasis patients. Lane H2O is the 
negative control using water istead of DNA. 
 
As can be seen from Figure 20, PCR with primers Leish45-F and Leish45-R 
results in the expected ladder of 83, 128, 173, 218, 263, ... bp DNA bands. In 
combination with the DNA size marker, this pattern would be sufficiently 
characteristic to identify Leishmania DNA. However, the assays result in clear results 
with DNA purified from cultivated parasites only. Using crude DNA as isolated from 
buffy coat, the results are not convincing because of the high background of 
addidional amplification products which make it difficult to recognize the correct 
bands. Thus, this approach was no further continued in much detail. 
 
3.5.4  64 basepair repeat-specific PCR 
None of the PCR approaches described so far were able to discriminate 
between L. major and L. infantum. Thus, it was attempted to search for an 
appropriate template occuring exclusively in L. infantum in order to identify patient at 
 
m    Lm   Lin     1       2       3       4      5       6      C     C 
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risk to develop visceral leishmaniasis.  Such a sequence was found again using the 
Tandem Repeats Finder program in the genome of L. infantum in the form of a 64 bp 
tandem repeat. This repeat occurs more than 400 times in different positions of 
chromosome 27 of the parasite. It is present neither in L.major nor in Trypanosoma 
cruzi and appeared to be an ideal target for PCR therefore.  
The sequence of this repeat (6 repeats) is depicted in Figure 21. As with the 
above described Leish45-repeat, Primer3 software was used to select optimal PCR 
primers.  
 
 
OLIGO            start  len      tm     gc%   any    3' seq  
LEFT PRIMER        167   20   59.57   45.00  4.00  2.00 AAAACGGGAATGCTCCAGTA 
RIGHT PRIMER       361   18   62.64   61.11  7.00  2.00 TTTCGCTGCGAGGGAGAC 
SEQUENCE SIZE: 384 
INCLUDED REGION SIZE: 384 
 
PRODUCT SIZE: 195, PAIR ANY COMPL: 4.00, PAIR 3' COMPL: 1.00 
 
    1 CGCGAAGCAATGCTCCCGCGAGGGTCTCCCTCGCAGCGAAAACGGGAATGCTCCAGTACT 
                                                                   
 
   61 GGGGCGCGAAGCAATGCTCCCGCGAGGGTCTCCCTCGCAGCGAAAACGGGAATGCTCCAG 
                                                                   
 
  121 TACTGGGGCGCGAAGCAATGCTCCCGCGAGGGTCTCCCTCGCAGCGAAAACGGGAATGCT 
                                                    >>>>>>>>>>>>>> 
 
  181 CCAGTACTGGGGCGCGAAGCAATGCTCCCGCGAGGGTCTCCCTCGCAGCGAAAACGGGAA 
      >>>>>>                                                       
 
  241 TGCTCCAGTACTGGGGCGCGAAGCAATGCTCCCGCGAGGGTCTCCCTCGCAGCGAAAACG 
                                                                   
 
  301 GGAATGCTCCAGTACTGGGGCGCGAAGCAATGCTCCCGCGAGGGTCTCCCTCGCAGCGAA 
                                                 <<<<<<<<<<<<<<<<< 
 
  361 AACGGGAATGCTCCAGTACTGGGG 
      <                        
 
Figure 21: DNA sequence and primer selection of the Leish64 repeat. The sequences of forward 
primer (red) and reverse primer (blue) are indicated. The corresponding areas on the DNA overlap as 
indicated (purple and underlined) what holds only for the (hypothetical) shortest PCR fragment. 
 
 
As can be seen from Figure 19, the primers Leis64-F and Leish64-R would 
lead to a  ladder of DNA fragments with lengths of 67, 131, 195, 259, 323, 387 ... bp. 
This was tested with DNA extracted from cultivated parasites as well as with buffy 
coat DNA from patients with visceral and cutaneous leishmaniasis. The results are 
shown in Figure 22. 
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Figure 22: PCR products obtained with primers Leish64-F and Leish64-R with DNA purified from 
cultivated L. major (Lm) and L. infantum (Lin) parasites, with DNA from buffy coat of two visceral 
leishmaniasis patients (v1 and v2), with buffy coat DNA of two cutaneous leishmaniasis patients (c1 
and c2) and with buffy coat DNA from two healthy German persons (D1 and D2), C = control PCR in 
the absence of DNA, m = size marker. 
 
As can be seen from Figure 22, the PCR with the primers Leish64-F and 
Leish64-R are not appropriate to differentiate between L. major and L. infantum. The 
reason for this is the high background arising even with DNA extracted from buffy 
coat of healthy German blood donors (lanes D 1 and 2). There are obviously 
sequences in the human genome which ross-react with these primers. The 
background could not be reduced by using higher annealing temperatures (not 
shown). Therefore, no further tests were performed with this set of primers. 
 
3.5.5  39 basepair repeat-specific PCR 
At last, a set of PCR primers was designed for a 39 bp repetition occuring 
more than 450 times exclusively in chromosome 22 of L. infantum in three different 
locations. No homologous sequences were detected in the genomes of L. major or 
Trypanosoma cruzi.  As before for the other tandem repeats, a fragment of five 
Lm  Lin    v1    v2     c1    c2     D1   D2     C      C     m 
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repeats was used to design optimal PCR primers using Primer3 software. The result 
of this calculation is shown in Figure 23.  
 
 
OLIGO            start  len      tm     gc%   any    3' seq  
LEFT PRIMER         78   25   51.80   32.00  6.00  2.00 CAAAGATGTATATAGACGTTAGTGT 
RIGHT PRIMER       163   22   56.11   36.36  2.00  0.00 CATCTTTGTTTGTGTGTTGTGT 
SEQUENCE SIZE: 195 
INCLUDED REGION SIZE: 195 
 
PRODUCT SIZE: 86, PAIR ANY COMPL: 8.00, PAIR 3' COMPL: 0.00 
 
    1 AAAGATGTATATAGACGTTAGTGTACACAACACACAAACAAAGATGTATATAGACGTTAG 
                                                                   
 
   61 TGTACACAACACACAAACAAAGATGTATATAGACGTTAGTGTACACAACACACAAACAAA 
                       >>>>>>>>>>>>>>>>>>>>>>>>>                   
 
  121 GATGTATATAGACGTTAGTGTACACAACACACAAACAAAGATGTATATAGACGTTAGTGT 
                           <<<<<<<<<<<<<<<<<<<<<<                  
 
  181 ACACAACACACAAAC 
 
 
Figure 23: DNA sequence and primer design for the 39 bp repeat of L. infantum. The sequences of 
forward primer (red) and reverse primer (blue) and overlaps (purple and underlined) are indicated as in 
Figure 19. The calculated size of the amplfication products is a ladder of 86, 125, 164, 203, 242, 281, 
320,    bp.  
 
 
Test of these primers with purified Leishmania DNA as template revealed that 
the primers were highly specific for L. infantum exclusively as shown in Figure 24. 
There was no cross-reaction with DNA from L. major (lane Lm) or Trypanosoma cruzi 
(not shown).  
With all of the 26 samples from patients suspected to have visceral 
leishmaniasis there is a amplification of DNA which could correspond to tri- tetra- and 
pentamers of the 39 bp repeat, even though the band pattern looks diffuse. In some 
of the samples the bands are better to be recognized than in the others. The L. major 
positive control Is always negative, and so is buffy coat DNA from healthy German 
persons (data not shown). Thus it looks like PCR using Leish39 primers is specific for 
the visceral form of leishmaniasis even though PCR products leading to sharper 
bands would be desirable. 
 
  
 
 
 
 
 
Figure 24: PCR amplification of Leishmania from buffy coat sample (lanes 1
from patients with suspected visceral leishmaniasis. 
positive control, L.inf = L. infantum
 
 
M = size marker, L
 positive control, and h2o = water as a negative control.
52 
-26) obtained 
.major = L. major 
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3.5.6  Compilation of the PCR results 
Even though the PCR procedures developed during this work need to be 
verified by well characterized patient samples, it is clear from the data that the 
methods used in Yemen up to now are not sufficiently sensitive.  
The primers used for the assays described above are listed in the following 
Table 5. 
 
Table 5. Primers for diagnsosis of Leishmaniasis 
 
Specificity Gene Primer name Sequence Size (bp) 
Tm 
(°C) 
Leishmania all 
species 
Minicircle 
(kDNA) 
Leishmini-F 
Leishmini-R 
ATTTTACACCAACCCCCAGTT 
GGG(G/T)AGGGGCGTTCTGC 113 
59.5 
61.6 
Leishmania all 
species 18S rRNA 
Leish18S-out-F 
Leish18S-out-R 
Leish18S-inn-F 
Leish18S-inn-R 
TCAGTCCATTTGGATTGTCA 
AGTACGTTCTCCCCCGAACT 
CAGGTTTGTTCCTGGTCGTC 
GAGTTGAAAAGGCGTTACGG 
480 
 
335 
64.3 
63.2.0 
60.5 
59.7 
Leishmania 
all species 45 bp repeat 
Leish45-F 
Leish45-R 
CGGAGCTGCTGCTGGAC 
GGCGTCCTCGTCGTCTG ladder 
62.0 
61.6 
L. infantum 64 bp repeat Linf64-F Linf64-R 
AAAACGGGAATGCTCCAGTA 
TTTCGCTGCGAGGGAGAC ladder 
59.6 
62.6 
L. infantum 39 bp  
repeat 
Linf39-F 
Linf39-R 
CAAAGATGTATATAGACGTTAGTGT 
CATCTTTGTTTGTGTGTTGTGT ladder 
51.8 
56.1 
 
During the study, 119 samples from patients with suspected cutaneous 
leishmaniasis have been collected in different locations in Yemen. These samples 
have first been analysed by microscopy of smears of wound material. It is agreed in 
the international literature that microscopical analysis alone has an insufficient 
sensitivity. Better results could be obtained by addidinal tests such as culivation or 
immunological techniques. However, these procedures are to expensive for use in 
Yemen. The results for the 119 patient samples obtained obtained in Yemen by 
microscopy are shown in the following Table 6. 
As can been seen, only 47 cases (39%) of the 119 cases were identified to be 
positive by microscopic examination. However, by the combined tests with kDNA- 
and 18S rRNA-specific PCR, 76 (64 %) samples were found to be positive.  
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Table 6: Clinical and epidemiological features from 119  patients with cutaneous 
leishmaniasis in Yemen. 
Patients features Positive* (%) Negative*(%) 
n = 47(39) n = 72(61) 
Sex 
Male 
Female 
  
25(53) 49(68) 
22(47) 23(32) 
Age (years) 
≤15 
15–34 
35–54 
55–64 
≥65 
  
14(30) 19(26) 
26(55) 39(54) 
5(11) 10(14) 
1 (2) 3(4) 
1(2) 3(4) 
Habitation 
Urban 
Periurban 
Rural 
  
9(19) 13(18) 
12(26) 18(25) 
26(55) 41(57) 
Duration (in months) 
1–6 
7–12 
≥12 
  
38(81) 56(78) 
9(19) 12(17) 
1(1) 3(4) 
Place of lesions 
Legs and feet 
Arms and hands 
Chest 
Head and face 
Multiple lesions 
  
5(11) 13(18) 
8(17) 24(33) 
0 0 
31(66) 34(47) 
3(6) 1(1) 
  * as determined by microscopy in Yemen 
 
Similar results have been obtained with the samples of patients with suspected 
visceral leishmaniasis. The 26 patients were diagnosis in the central blood bank in 
Sana’a, Yemen, by both ELISA and formol gel examination. 8 cases have been 
classified according to these criteria as positive. The data are shown in Table 7.   
From the patients identified as positive 4 were male (50%) were and 4 were 
female (50%). The majority of the positive patients (62%) were in the age group 15-
34  years and in the age group less than 15 years (25%). The highest prevalence of 
disease (62%) was seen in the urban areas.  
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Table 7: Clinical and epidemiological features from 26 patients with suspected  
visceral leishmaniasis in Yemen. 
Patients features 
Positive*(%) Negative* 
(%) 
n =8 (31) n = 18 (69) 
Sex 
Male 
Female 
  
4(50) 11(61) 
4(50) 7(39) 
Age (years) 
≤15 
15–34 
35–54 
55–64 
≥65 
  
2(25) 0 
5(62) 13(72) 
1(12) 4(22) 
0 1(6) 
  
Habitation 
Urban 
       Periurban 
Rural 
  
5(62) 13(72) 
3(37) 4(22) 
0 1(6) 
Duration (in months) 
1–6 
7–12 
≥12 
  
1(12) 9(50) 
3(37) 7(39) 
4(50) 2(11) 
Symptoms 
Hepatomegaly 
Splenomegaly      
Hepatosplenomegaly 
  
2(25) 10(56) 
4(50) 3(17) 
2(25) 5(28) 
* as determined by the combination of a Leishmania-specific ELISA and 
             formol precipitation assay in Yemen 
 
Analysis of buffy coat DNA samples from the same patients in the laboratory in 
Giessen by the different PCR assays described above yielded a different result. Even 
if these assays need to be validated by additional tests and there were some 
inconsitencies between the single PCR runs, it is obvious that the molecular 
approach is much more sensitive than the traditional procedures used in Yemen. 
Combination of kDNA-specific PCR and 18S rRNA-specific PCR led to 76 positive 
results out of the 119 samples indicating that 64 % of the suspected  cutaneous 
leishmaniasis patients were actually infected. By microscopy, only 39 % of the 
patients had been recognized as positive.   
As with the coutaneous leishmaniasis, also the data for the patients with 
suspected visceral leishmaniasis obtained in Germany were much higher. By 
combining the PCR data from rDNA-, 18S rRNA- and Leish39-specific PCR, 16 
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cases (62 %) were found to be positive. Even though the results with the new PCR 
techniques are preliminary and need to be confirmed, the results show clearly that 
the occurence of leishmaniasis in Yemen is highly underestimated. 
 
Table 8: Comparison of PCR and traditional methods in patients with leishmaniasis  
 
suspected cutaneous 
leishmaniasis patients 
PCR Microscopy 
positive negative positive negative 
119 (100 %) 76 (64 %) 43 (36 %) 47 (39 %) 72 (61 %) 
 
suspected visceral 
leishmaniasis patients 
PCR ELISA Formol gel 
positive negative positive negative positive negative 
26 (100 %) 16(62%) 10(38%) 2 (8 %) 3 (12%) 6 (23 %) 15(58%) 
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4.  DISCUSSION  
The Republic of Yemen is a developing country with very poor health 
conditions. According to the Ministry of Public Health and the National Center for 
Surveillance and Disease Control, deaths among children under five years of age are 
mainly due to infectious diseases such as diarrhea with an estimated 45,000 and 
malaria reaching about 25.000 cases of death per year. According to the  U.S.A. 
Census Bureau (http://www.census.gov/ipc/prod/wp02/tabA-11.pdf), the total children 
mortality within the first 5 years of life in Yemen is 92 per 1000, ranging amongst the 
last 20 % countries worlwide (for comparison: in Europe this number is 6 per 1000). 
These data are indicatory for the poor quality of life in this country and for the realistic 
possibilities to improve heath conditions. 
The aim of this study was first to shed some light on the real extent of 
leishmaniasis in Yemen, and second, to contribute to the development of a more 
trustable diagnosis than the traditional procedures used in the country such as 
microscopy and serum precipitation with formaldehyde. The limiting sensitivity and 
specificity of these traditional methods are well known, but the limiting economical 
conditions in Yemen do not allow the use of more sensitive and specific diagnostic 
techniques such as modern immunoassays with recombinant antigens. New 
diagnostic techniques to be established in the country should not only be highly 
specific and sensitive, but also inexpensive and simple to be applicable under the 
given limiting conditions. This latter goal was followed in our laboratory at the 
University of Giessen in two different ways: one approach included the development 
of recombinant antigens capable to discriminate between cutaneous and visceral 
leishmaniasis for use in simple and inexpensive immunoassays (ELISA and 
immunochromatographic test stripes) which was topic of another doctoral thesis 
(Heimann, 2008). The second approach, which is realised in this work, was the 
development of molecular diagnostic tests in the form of different PCR assays.  
The basis for both approaches were the comlete genomic sequences of three 
Leishmania strains (L. major, L. infantum and L. brasiliensis) together with the closely 
related genome of Trypanosoma cruzi wich are available free of charge since a short 
time in the internet. Many computer programmes needed to handle these huge 
amounts of genetic information (more than 100 million basepairs) are equally free 
accessible from the internet. 
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4.1  Epidemiology of leishmaniasis 
There are no solid data on the incidence of Leishmania infections in Yemen, 
but the disease is certainly under-reported, especially in women and children, and 
may exceed 10.000 cases per year. Most cases correspond to cutaneous 
leishmaniasis due to infections with L. major and L. tropica which may not necessarily 
need treatment, but up to 10 % of the infections may be due to L. infantum leading to 
visceral leishmaniasis which is associated with up to 90% mortality when untreated.  
There are only few reports on leishmaniasis in Yemen in the literature (Sarnelli 
1933; Rioux 1986; Pratlong et al. 1995: Khatri et al., 2006) which can be used to 
predict the parasite strains circulating in the country (L. major and L. tropica for 
cutaneous leishmaniasis and L. infantum for visceral leishmaniasis), but these 
publications do not indicate the frequency and severity of the disease in the 
population. In order to get more information on the occurence of leishmaniasis, data 
collected during the years 2005-2008 by the the National Center of Surveillance of 
Disease from all governmental hospitals in the 20 governorates were analysed (Table 
1). However, these data can only be used in a qualitative way, but they are by no 
means quantitative. Data obtained during a visit of the (private) Alolfi Hospital in the 
Alhodeidah governorate indicated 105 cases during the same period of time (2005-
2008) in this single place which is twofold the number of cases reported by the 
government for the whole governate (53 cases).  
The closest countries with similar kinds of Leishmania strains, phlebotomine 
vectors and comparable geographic conditions are Oman in the East, Saudi Arabia in 
the North-West and, in a distance of some 2000 km North-West from Yemen, Jordan 
and Palestine. Some usful epidemiological data exist from Saudi Arabia (al-Zahrani 
et al., 1989 and Ibrahim et al., 1992), wheras most informatve data have been 
published for Jordan and Israel (Nimri et al., 2002; Wasserberg et al., 2002; Al-
Jawabreh et al., 2003; Al-Jawabreh, 2005; Singer et al., 2009; Amro et al., 
2009;Hamarsheh et al., 2009). These data could form a basis for the understandig of 
leishmaniasis in Yemen. As in Yemen, two forms of transmission of the disease exist: 
in urban areas the parasites are transmitted from infected individuals by the bite of 
phlebotomine sand flies to naïve persons (anthroponotic cutaneous leishmaniasis), 
whereas In rural areas animals are thought to be the reservoir (zoonotic cutaneous 
leishmaniasis). The anthroponotic form of disease is frequent in large cities where 
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many people live close together under poor hygienic conditions. The vectors can 
multiply in small water resevoirs close to the dwellings as illustrated by the following 
pictures (Figure 25). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Conditions for anthroponotic cutaneous leishmaniasis. In many cities of Yemen, 
leishmaniasis is not dependent on animal hosts, but is transmitted by sand flies directly 
from infected individuals to naïve persons. In such loations the infection rate can be 
very high. The larvae of the sand flies can perfectly thrive in nearby water pools. 
 
Hosts involved in the transmission of the zoonotic form of the disease include 
primarily dogs and small rodents living in arid regions. In the neighbouring contries 
Iran, Jordan and Israel host species such as Psammomys obesus, Rattus rattus, 
Gerbillus dasyurus, Nesokia indica, Rhombomys opimus and Meriones spp. 
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(Wasserberg et al,. 2002; Yaghoobi-Ershadi et al., 2004; Pourmohammadi et al., 
2008) and rock hyraxes (Svobodova et al., 2006) have been found to be infected with 
Leishmania species. Which of these animals occure in Yemen remains to be 
determined. Among the Saudi populations in the south-west of Saudi Arabia (Asir 
and Al-Baha provinces), an annual incidence of 12 and 38 per 10,000 respectively 
was estimated for cutaneous leishmaniasis, mainly caused by L. tropica (al-Zahrani 
et al., 1989), whereas for the Jordan Valley an average of 7.5 cases per 10,000 per 
year was calculated (Mosleh et al., 2008). 
Seasonality of cutaneous leishmaniasis 
According to data collected from the Ministry of Health and National Centre for 
Surveillance and Disease Control the prevalence of leishmaniasis in the coastal 
governorates of Yemen is saisonal, ranging from October to April. This has been 
confirmed in this study during collecting samples from October 2004 to March 2005. 
Another study on patients in mountainous governorates showed a striking difference 
in seasonality, starting in June and reching till October. The reasons for seasonality 
of outbreak of the disease are the activity of sand fly vectors and the incubation 
period of the infection. L. major has an incubation period that ranges from a few 
weeks to a few months, but is longer for L. tropica which may take 2 -24 months 
(Harrison’s Principles of Internal Medicine, Chapter 205, Leishmaniasis. 1991). Ph. 
papatasi, vector of L. major, has its activity and abundance peaks in the spring (April) 
and the autumn (October), and was found to be not active in mid-summer (July) 
(Wasserberg et al., 2002).  
Another interesting phenomenon with cutaneous leishmaniasis is the fact, that 
men and children are by far more affected by the disease than women. This may be 
explained by behavioural or cultural factors which make males more exposed than 
females, and lack of immunity to make children more exposed than adults (Al-
Jawabreh et al., 2003). 
In summary it can be concluded that the epidemiological situation is 
comparable to the neighbouring countries. As the epidemiology of leishmaniasis of 
these countries is best described for Palestine, these data may serve as a basis to 
elucidate the situation in Yemen. However, this was not the purpose of this work, but 
has to be done by future analyses. 
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4.2  Diagnosis of leishmaniasis 
Health indicators for Yemen are poor, with high infant and maternal mortality 
rates as stated above. The per capita health expenditures are as low as 33 US Dollar 
per year, and government spending on health was only 3.3 per cent of total public 
expenditure, a proportion that is the fourth smallest among World Health 
Organisation (WHO) member states (CSO [Central Statistical Organization], Republic 
of Yemen. Demographic and Maternal and Child Health Survey 1998).  
This facts have to be kept in mind when planning to improve the health 
situation in the country by introducing new methods for the diagnosis of disease. 
Commercial diagnostics for infectious diseases are too expensive to be used under 
such conditions, however, the progress in molecular biology in the past years allows 
to produce essential diagnostic tools such as recombinant antigens, monoclonal 
antibodies or molecular probes at costs which can be afforded also by poor countries. 
The material costs for highly sensitive and specific tests such as ELISA with 
recombinant antigens, of molecular diagnosis using PCR are few cents per assay 
and the tests can be produced independent from external support inside the country 
when the essential theoretical and practical knowledge has been achieved. 
Purpose of the experimental work of this thesis was to develop molecular 
methods for the diagnosis of Leishmania infections in Yemen in a most simple way. 
This could be realized using DNA sequence data for different Leishmania species 
available through the internet in combination with free available computer 
programmes which are needed to process the huge amount of genetic information. 
Five different PCR assays have been designed and tested, and some of them turned 
out to possess a good potential for specific and sensitive diagnosis of leishmaniasis. 
 
4.3  Collection and processing of patient samples 
In planning inexpensive molecular tests for developing countries it is also 
essential to have appropriate methods for collecting samples from patients, for 
processing these samples and for conservation of the essential components under 
field conditions. In general, there is litte chance to keep such samples in a freezer at -
20°C, and even normal refrigerators are not always available. Traditionally, srapings 
from leishmanial ulcers are used for microscopical analysis. However, frequently only 
few, or no parasites at all, are contained in such samples. Better sources for 
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parasites are biopsies from the border of the ulcer, from lymph nodes, from bone 
marrow, or from spleen. However, biopsies can hardly be taken under field 
conditions, but alternatively, few millilitres of peripheral blood can be taken with a 
syringe without the risk of accidental infection or cross-contamination. The parasites 
amplify mainly in macrophages, and even in the chronical stage of disease sufficient 
infected white blood cells can be detected in the circulation.  
A simple method for blood collection and processing under field conditions has 
been developed in our laboratory in Giessen. The protocol is described in the 
Materials and Methods section. In short, blood is collected in syringes containing 
EDTA or citrate as anti-coagulant. Blood cells are sediment by centrifugation (a 
simple hand-operated centrifuge has been used during this work, see Figure.10), the 
supernatant plasma was collected and conserved in 50 % glycerol, and finally, the 
yellow layer of white blood cells and platelets (buffy coat) was harvested with a 
pipette. The excess of red blood cells in this crude buffy coat preparation were lysed 
by a low ionic stength buffer, the cells sedimented again by short centrifugation and 
mixed with a guanidinium hydrochloride solution. The guanidinium hydrochloride has 
two functions: first, it lyses the cells for later DNA extraction, and second, it protects 
the DNA for extended periods of time (months) from degradation even at ambient 
temperatures.  
The DNA from the lysed white blood cells was lateron easily purified in the 
laboratory by adding small amounts of silica (pulverized SiO2 which binds exclusively 
DNA under these conditions), several washing steps with diluted ethanol and finally 
eluted in pure and concentrated form by a low salt buffer. This procedure proved to 
be very appropriate for field conditions as no toxic chemicals such as phenol and 
chloroform are needed, and the costs of consumables are minmal. Furthermore, the 
whole procedure can be carried out in a single tube, which is important in terms of 
avoiding cross-contamination. DNA obtained by this way was used to test new PCR 
assays, and the plasma fraction was used to test new immunological assays by 
another member of the group. 
 
4.4  Kinetoplast DNA (kDNA)-specific PCR 
The first test developed was a PCR with primers specific for the kinetoplast 
DNA of Leishmania which consists of approximately 10.000 copies of circular DNA 
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molecules ("minicircles") containing a conserved sequence of approximately 120 bp. 
This DNA has been perfered for PCR diagnosis by many groups because due to the 
high copy number of target sites, less than a single parsite could be detected 
theoretically. kDNA-PCR has repeatedly been found to be the most sensitive of 
diagnostic assays for leishmaniasis (Lachaud et al., 2002; Nasereddin et al., 2006; 
Romero et al., 2009). 
The common part of the kDNA minicircles is not perfectly conserved, but 
consensus sequences can be found at the two ends of a more conserved region of 
approximately 120 bp. These consensus sequences have been used to develop 
primers for PCR amplification by others (references see above). According to the 
Prime3 software used for selection of PCR primers, the published primers appeared 
to be not optimal, basically because forward and reverse primers revealed 
differences in the annealing temperatures of more than 20°C. This is not appropriate 
for specific PCR since the hybridization temperature has to be set according to the 
primer with the lower binding strength. The other primer can bind under these 
conditions also to sites which do not match perfectly, thus creating unspecific 
background amplification. Therfore, it was attempted to predict primers with more 
equal annealing temperatures. The performance of the resulting (shorter) primers in 
kDNA-specific PCR assays was compared with the efficiency of the primers used by 
other groups, but no significant difference in sensitivity and specificity were observed.  
The kDNA-specific PCR assay developed by this way appeared to be most 
sensitive, however, it did not discriminate between cutaneous and visceral 
leishmaniasis. Furthermore,  processing of the results was somewhat demanding 
because the small resulting amplification product of 113 bp could only be redissolved 
on 6 % polyacrylamide gels. Therefore, some alternative PCR assays were 
developed in addition. 
 
4.5  18S ribosomal RNA-specific PCR 
Leishmania species contain approximately 160 copies of the genes for the 
small subunit of ribosomal RNA (18S rRNA or ssu rRNA). These genes have been 
used by several groups as target for diagnostic PCR, even though most of them were 
using different sets of primers (Spanakos et al., 2002; Schönian et al., 2003; Chargui 
et al., 2005). It is agreed within all these groups that 18S rRNA-specific PCR is highly 
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sensitive, superior to PCR assays with other target genes in the Leishmania genome. 
The genes for the 18S rRNA are highly conserved between the different species of 
Leishmania, thus, discrimination within the genus is not possible. However, clear 
discrimination is feasible from other species such as the closely related Trypanosoma 
cruzi, or the non-pathogenic Trypanosoma rangelli which occurs frequently in Latin 
America. Only part of the sequence of the gene can be used for establishing 
discriminatory PCR because of the high degree of homology of 18S rRNA sequences 
between all organisms, However, some regions differ sufficiently to be appropriate for 
this purpose.  
By means of Primer3 software, two sets of PCR primers were selected to 
produce a fragment size that could be easily analysed be agarose gel 
electrophoresis. Due to the lower gene copy number as compared with kDNA, it 
appeared to be necessary to employ nested PCR using a second set of primers. The 
disadvantage of a second amplification cycle is compensated not only by higher 
sensitivity, but also by a higher specificity. The second set of primers leads to 
enrichment of correct amplification products only, thus avoiding false positive results.  
The first PCR with the outer set of primers led only in few cases to a visible 
band on agarose gels (see Figure 15). This could be due to several reasons. First, 
one or both primers are not optimal and higher sensitivity could be reached with 
alternative primers. However, also the set of inner primers, when used alone, did not 
lead to more sensitivity. Another reason for this fact could have been the relative low 
amont of DNA used for the assays. The DNA of the samples from Yemen was limited 
and had to be spared for many other assays. Normally not more than 2 per cent of 
the DNA isolated from one sample were used per assay. Taking 10 per cent of DNA 
from a sample would probably improve the sensitivity markedly. Furthermore, in all 
assays a self-made Taq DNA polymerase was used which may not have the same 
quality as expensive commercial enzymes. Nevertheless, clear results were obtained 
with nested PCR using aliquots of the amplification products of the first PCR as 
template for the second PCR with inner primers. The sensitivity was almost as high 
as obtained with the kDNA-specific PCR, and the fact that the fragments can be 
easily separated on agarose gels allows to use this test in large scale. To compare 
the quality of this test with other 18S rRNA-specific PCR assays, tests with PCR 
primers used by other groups need to be done. 
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4.6  PCR assays with tandem repeat sequences 
The three completely sequenced Leishmania strains (L. major, L. infantum and 
L. brasiliensis) accessible in the Sanger Gene Database contain plenty of tandemly 
repeated sequences. Using the "Tandem Repeats Finder" computer program 
(http://tandem.bu.edu/trf/trf.html), the three genomes were analysed for tandem 
repeats in the DNA. This analysis revealed many different repeats with different 
lengths of the repetitive unit. The highest number were more than 1000 repeats of a 
45 nucleotide sequence, other repeats with lengths between ten and more than 100 
nucleotides occured somewhat less frequently, but several hundred repetitions were 
not uncommon. Approximately 10 per cent of the genomes consist of such repetitive 
sequences. The repeats were usually fragmented in several subfractions (2-10) 
distributed in the same, but also in different chromosomes. Some repeats were highly 
conserved, others differed up to 10 per cent in the nucleotide composition of the 
single units. Most of the repeats occured in related form in all three Leishmania 
strains even though in different numbers. However, there were several repeats 
specific for a single strain thus representing candidates for species-specific PCR. 
Some repeats were also to be observed in related form in the genome of 
Trypanosoma cruzi. 
The repeats occure in non-coding as well as in protein coding regions of the 
genomes. In coding regions, they are translated in tandem arrays of amino acid 
sequences which are in part highly immunogenic leading to a strong antibody 
reaction. Such tandem arrays of amino acids have been used in recombinant form as 
antigens for developing specific immunoassays such as the K39 antigen (Burns etal., 
1993).  
As these tandemly repeated sequences differ in part between the three 
Leishmania species, it seemed to be interesting to test if they could serve as targets 
for specific PCR assays. In contrast to normal PCR, the amplification products were 
not expected as a single band of defined length, but as a ladder of bands with 
distances between the different steps corresponding to the length of a single repeat 
unit. By means of the primer3 software appropriate primers were selected for three 
such repeats: the 45 basepair repeat with approximately 1000 copies occuring  in all 
strains, a 64 basepair repeat with a frequency of approximately 400 copies common 
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to all strains as well, and a 39 basepair repeat present in L. infantum exclusively. 
None of these repeats was present in related form in Trypanosoma cruzi.   
As can be seen from the Results section, the PCR amplification of these 
repeats worked out in principle as predicted, however, the results were not as 
convincing as expected. Even though the 45 basepair repeat led to a characteristic 
ladder with the purified DNAs of L. major and L. infantum, this ladder diaspeared 
almost completely when the Leishmania DNA was mixed with buffy coat DNA. 
Obviously, human DNA contains many sequences which serve as template for the 
primers used in this PCR. The results were not much different under more stringent 
conditions, i.e when the highest possible annealing temperature for these primers 
was selected.  
The results with the PCR specific for the 64 basepair repeat looked even 
worse. The primers led to strong background reactions even with the purified parasite 
DNAs indicating a too low selectivity of this PCR. 
However, the 39 basepair specific PCR led to results which look promising for 
diagnosis. The resulting ladder of bands is specific for L. infantum, that means for 
visceral leishmaniasis (Figure 19). There is no background reaction in controls 
without DNA and with buffy coat DNA from patients with cutaneous leishmaniasis 
(not shown in the Figure). The lowest bands of the ladder are not visible in the 
amplification products with buffy coat DNA from visceral leishmaniasis patients, 
however, higher multimeric forms are present, at least in some of the lanes. As with 
the 18S rRNA-specific PCR, the weak reaction may be due to the limiting amounts of 
DNA added to the assays. In any case it appears to be worthwhile to repeat this 
approach with more DNA. In addition, the stringency of the assay could probably be 
improved, and alternative primers specific for the 39 basepair repeat could be tested. 
The PCR may not be sufficient as only test, but it could be used as a second test 
after demostration of the infection either by kDNA- or 18S rRNA-specific PCR. 
 
4.7  Concluding remarks 
Leishmaniasis is still a widely negected disease which means that even though 
millions of people in developing countries suffer from the infection, there are neither 
appropriate diagnostic procedures nor sufficiently effective drugs for treatment available. At 
present, several groups worldwide study the variability of Leishmania strains with complex 
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techniques such as analysis of enzyme polymorphismes, restriction length polymorphism, or 
determination of microsatellite patterns of the organisms. Even though these techniques 
contribute to evaluate the genetics and epidemiology of the parasite in much detail, they are 
by far too demanding to be used for answering the simple question: is there an infection with 
Leishmania or not? To reduce suffering from this disease, prove of the infection has to be 
simple and inexpensive since it affects mainly the poorest of the poor.  
The first step of diagnosis has to discriminate between an infection with Leishmania 
and other causes of the dermal ulcer which may have bacterial or fungal origin. Only in a 
second step is needed to differentiate between cutaneous and potentially visceral 
leishmaniasis in the Old World, or between cutaneous, and mucocutaneous leishmaniasis in 
the New World. As up to 20 per cent of all cutaneous cases in Latin America develop to the 
mucocutaneous form after some time, a proven Leishmania infection is treated anyway and 
this discrimination may not be needed therefore. A detailed analysis of the specific strain 
may be helpful for the prognosis of disease and for the prediction of drug-resistancy, but this 
is not the first priority.  
Because of the severe side effects of the drugs, cutaneous leishmaniasis in the Old 
World is normally only treated if the ulcers are severe and could have disfiguring 
consequences. However, since also the life-threatening visceral form of the disease begins 
with a cutaneous ulcer as a first clinical symptom, it will be needed in the future to decide 
already in this early stage whether the ulcer is caused by a cutaneous form (L. tropica and L. 
mayor in the Arabian peninsula), or by the dangerous visceral form (L. donovani or L. 
infantum). There are good immunodiagnostic assays available, mainly based on the 
recombinant antigen rK39, but these assays are not sufficient because specific antibodies 
can persist for many years and it is difficult to decide, wether they derive from an healed 
infection, or indicate acute disease. Therefore, a simple and inexpensive molecular test 
would be very helpful. 
It was goal of this work to contribute to this aspect. Even though the assays 
established so far could be improved to a certain degree, it becomes obvious that PCR  
diagnosis is extremely useful and not as complicated and expensive that it could not be 
introduced to Yemen. For this purpose it was also essential that procedures basic for PCR 
diagnosis, the collection of patient samples, the conservation of the essential fractions DNA 
and plasma, the isolation and purification of DNA and the preparation of Taq DNA 
polymerase have been simplified in such a way that they can also be performed in a low 
equiped laboratory and for little money. 
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